ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
North Central Cancer Treatment Group
Breast International Group
NCIC Clinical Trials Group
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00490139
First received: June 20, 2007
Last updated: April 3, 2014
Last verified: March 2014
  Purpose

This is a randomised, open label multi-centre phase III study comparing the activity of lapatinib alone versus trastuzumab alone versus trastuzumab followed by lapatinib versus lapatinib concomitantly with trastuzumab in the adjuvant treatment of patients with ErbB2 overexpressing and/or amplified breast cancer. Patients will be enrolled according to one of two design schemas, with Design 2 having two chemotherapy options (Design 2 and 2B), and will be randomised to one of four treatment regimens within each design schema.

The primary objective of this study is to compare disease-free survival (DFS) in patients with HER2 overexpressing and/or amplified breast cancer randomised to trastuzumab for one year versus lapatinib for one year versus trastuzumab (12 or 18 weeks, according to assigned design) followed by a six-week treatment-free interval followed by lapatinib (28 or 34 weeks, according to assigned design) versus trastuzumab in combination with lapatinib for one year (52 weeks). Secondary objectives include treatment comparisons with respect to overall survival, time to recurrence, time to distant recurrence, safety and tolerability, incidence of brain metastasis, and analyses conducted separately for cohorts of patients defined by presence or absence of cMyc oncogene amplification, expression level of PTEN and presence or absence of the p95HER2 receptor. On August 18, 2011, the ALTTO Independent Data Monitoring Committee (IDMC) met to review the first planned interim analysis. The IDMC reported that the comparison of lapatinib alone versus trastuzumab alone crossed the futility boundary, indicating that the lapatinib alone arm was unlikely to meet the pre-specified criteria to demonstrate non-inferiority to trastuzumab alone with respect to disease-free survival (DFS). The IDMC also stated that the other three arms (trastuzumab alone, sequential trastuzumab/lapatinib arm and the combination arm) should continue as planned with no changes.


Condition Intervention Phase
Neoplasms, Breast
Drug: Lapatinib
Biological: Trastuzumab
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Randomised, Multi-centre, Open-label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients With HER2/ErbB2 Positive Primary Breast Cancer

Resource links provided by NLM:


Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:
  • Disease-free survival [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Overall survival [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Time to recurrence [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Time to distant recurrence [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Incidence of brain metastases as first site of breast cancer recurrence [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Safety and Tolerability [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Conduct analyses separately for cohorts defined by the presence or absence of cMyc gene amplification [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Conduct analyses separately for cohorts defined by the expression levels of PTEN [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]
  • Conduct analyses separately for cohorts defined by the presence or absence of p95HER2 domain [ Time Frame: Approximately 6-10 years ] [ Designated as safety issue: No ]

Enrollment: 8381
Study Start Date: May 2007
Estimated Study Completion Date: November 2022
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Arm 1: Trastuzumab

Design 1: Trastuzumab 8mg/kg IV loading dose followed by 6mg/kg IV every 3 weeks for a total of 52 weeks.

Design 2: Either paclitaxel 80mg/m2 IV weekly for 12 weeks OR docetaxel 75mg/m2 IV every 3 weeks for 4 cycles administered concomitantly with trastuzumab 4mg/kg IV loading dose followed by 2mg/kg IV weekly. After completion of chemotherapy, trastuzumab administered every 3 weeks (6mg/kg IV without loading dose) for an additional 40 weeks (52 weeks total).

Design 2B: Docetaxel 75mg/m2 and carboplatin AUC 6 every 3 weeks for 6 cycles (18 weeks) administered concomitantly with trastuzumab 4mg/kg IV loading dose followed by 2mg/kg IV weekly. After completion of chemotherapy, trastuzumab (6mg/kg without loading dose) every 3 weeks for an additional 40 weeks (52 weeks total).

Biological: Trastuzumab
Antibody
Experimental: Arm 2: Lapatinib

Based on the IDMC results from 18 August 2011, any patient enrolled onto Arm 2 should be considered for a new treatment strategy based on discussion with their physician.

Design 1: Lapatinib 1500mg oral daily for a total of 52 weeks.

Design 2: Either paclitaxel 80mg/m2 IV weekly for 12 weeks OR docetaxel 75mg/m2 IV every 3 weeks for 4 cycles administered concomitantly with oral lapatinib at 750mg daily. After completion of chemotherapy, oral lapatinib administered at 1500mg daily for an additional 40 weeks (52 weeks total).

Design 2B: Docetaxel 75mg/m2 and carboplatin AUC 6 every 3 weeks for 6 cycles (18 weeks) administered concomitantly with oral lapatinib at 750mg daily. After completion of chemotherapy, the dose of lapatinib will be increased to 1500mg oral daily for an additional 40 weeks (52 weeks total).

Drug: Lapatinib
Small molecule inhibitor
Other Name: Lapatinib
Experimental: Arm 3: Trastuzumab followed by Lapatinib

Design 1: Trastuzumab (4mg/kg IV loading dose followed by 2mg/kg IV weekly) for 12 weeks followed by a 6 week treatment-free interval followed by oral lapatinib 1500mg daily for 34 weeks (52 weeks total).

Design 2: Trastuzumab (4mg/kg IV loading dose followed by 2mg/kg IV weekly) for 12 weeks administered concomitantly and either paclitaxel 80mg/m2 IV weekly for 12 weeks OR docetaxel 75mg/m2 every 21 days for 4 cycles; followed by a 6 week treatment-free interval followed by oral lapatinib 1500mg daily for 34 weeks (52 weeks total).

Design 2B: Docetaxel 75mg/m2 and carboplatin AUC 6 every 3 weeks for 6 cycles (18 weeks) administered concomitantly with trastuzumab (4mg/kg IV loading dose followed by 2mg/kg IV weekly) followed by a 6 week treatment-free interval followed by oral lapatinib 1500 mg daily for 28 weeks (52 weeks total).

Biological: Trastuzumab
Antibody
Experimental: Arm 4: Lapatinib in combination with Trastuzumab

Design 1: Oral lapatinib 1000 mg daily concurrent with trastuzumab 8 mg/kg IV loading dose followed by 6mg/kg IV every 3 weeks (52 weeks total).

Design 2: Trastuzumab (4mg/kg loading dose followed by 2mg/kg IV weekly) concurrent with oral lapatinib 750 mg daily and either paclitaxel 80mg/m2 IV weekly for 12 weeks OR docetaxel 75mg/m2 every 21 days for 4 cycles (12 weeks). After completion of chemotherapy, the dose of lapatinib will be increased to 1000mg daily concurrently with trastuzumab every 3 weeks (6mg/kg without loading dose) for an additional 40 weeks (52 weeks total).

Design 2B: Docetaxel 75mg/m2 and carboplatin AUC 6 every 3 weeks for 6 cycles (18 weeks) administered concurrently with oral lapatinib 750mg plus weekly trastuzumab (4mg/kg IV loading dose followed by 2mg/kg IV. After the completion of chemotherapy, trastuzumab will be administered every 3 weeks (6mg/kg without loading dose) concurrent with lapatinib 1000mg daily for an additional 40 weeks (52 weeks total).

Drug: Lapatinib
Small molecule inhibitor
Other Name: Lapatinib
Biological: Trastuzumab
Antibody

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age ≥ 18 years
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤ 1;
  • Non-metastatic operable primary invasive adenocarcinoma of the breast fulfilling the following:

    1. Histologically confirmed
    2. Adequately excised (exceptions: patients who have 'non-resectable' deep margin invasion are eligible provided they have had or will receive radiotherapy encompassing the region concerned; patients with histologically documented infiltration of the skin (pT4) are eligible provided they have undergone or will receive radiotherapy encompassing the tumour bed);
    3. Axilla dissected; sentinel node sampling is allowed provided that axillary dissection follows confirmation of a positive sentinel node; sentinel node sampling alone is NOT acceptable after neoadjuvant chemotherapy (in patients receiving neoadjuvant chemotherapy lymph node status will be considered unknown, regardless of the results of post-chemotherapy axillary dissection);
    4. Axillary node positive patient OR node negative patient with a tumour greater than or equal to 1.0 cm in greatest diameter. For clarification, isolated tumour cells (ITC) are considered pN0 and micrometastases are considered pN1
  • Known hormone receptor status (ER/PgR or ER alone)
  • For Designs 1 and 2: Patients must have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen or listed as an exception in Table 5 of the protocol.

For Design 1: Randomization must be performed no longer than 12 weeks from day 1 of the last chemotherapy cycle after obtaining a post-chemotherapy LVEF ≥ 50. Study treatment must start no more than 14 days after randomization For Design 2: Randomization must be performed no longer than 6 weeks from day 1 of the last anthracycline-containing chemotherapy cycle after obtaining a post-anthracycline chemotherapy LVEF ≥ 50. Study treatment must start no more than 14 days after randomization and must be concurrent with taxanes.

For Design 2B: Randomisation must be performed no longer than 8 weeks from definitive surgery. Non-anthracycline platinum containing regimen (docetaxel and carboplatin) and study treatment must start concomitantly and no more than 14 days after randomisation.

  • Baseline LVEF ≥50% measured by echocardiography or MUGA scan. For Design 1 and Design 2 - after completion of all anthracycline-based (neo-) adjuvant chemotherapy and prior to the targeted therapy(ies); for Design 2B - prior to targeted therapy(ies) and chemotherapy (docetaxel and carboplatin)
  • Over expression and/or amplification of HER2 in the invasive component of the primary tumour (in case of neoadjuvant treatment, tissue sample used for HER2 testing should be collected before neoadjuvant treatment starts), according to one of the following definitions [Wolff et al 2007] and confirmed by central laboratory prior to randomization:
  • 3+ over expression by IHC (> 30% of invasive tumour cells);
  • 2+ or 3+ (in 30% or less neoplastic cells) over expression by IHC AND in situ hybridization (FISH/CISH) test demonstrating HER2 gene amplification;
  • HER2 gene amplification by FISH/CISH ( > 6 HER2 gene copies per nucleus, or a FISH ratio [HER2 gene copies to chromosome 17 signals] of > than 2.2.) Patients with a negative or equivocal overall result (FISH test ratio of ≤ 2.2, ≤ 6.0 HER2 gene copies per nucleus) and staining scores of 0, 1+, 2+ or 3+ (in 30% or less neoplastic cells) by IHC are not eligible for participation in the trial.

Equivocal local results may be submitted for a final determination by the central laboratory.

  • Completion of all necessary baseline laboratory and radiological investigations
  • Signed written informed consent (approved by an Independent Ethics Committee (IEC) and obtained prior to any study specific screening procedures).

Exclusion Criteria:

  • History of any prior (ipsi- and/or contralateral) invasive breast carcinoma;
  • Past (less than 10 years) or current history of malignant neoplasms, except for curatively treated 1) basal and squamous cell carcinoma of the skin or 2) carcinoma in situ of the cervix.

NOTE: Patients with a prior malignancy diagnosed greater than 10 years in the past who have been curatively treated with surgery ONLY, WITHOUT radiation therapy or systemic therapy (chemotherapy or endocrine) are eligible for the study. Patients with any prior diagnosis of breast cancer or melanoma, at any time, are excluded from this study.

  • Any clinically staged T4 tumour, including inflammatory breast cancer;
  • Bilateral tumours;
  • This exclusion criterion has been removed as of protocol amendment 1.

NOTE: multifocal/multicentric tumours are permitted:

  • If the patient is node-negative: one of the lesions must be equal or greater than 1.0 cm (sum of the lesion diameters is not acceptable) AND must have positive HER2 status centrally-confirmed;
  • If patient is node-positive: lesion size does not matter BUT one of the lesions must have HER2 positivity centrally-confirmed. If several lesions are found to be HER2 positive locally, the largest lesion should be considered for central review.
  • Maximum cumulative dose of doxorubicin >360mg/m² or maximum cumulative dose of epirubicin >720mg/m² or any prior anthracyclines unrelated to the present breast cancer;
  • (Neo-) or adjuvant chemotherapy using peripheral stem cell or bone marrow stem cell support;
  • Any prior mediastinal irradiation except internal mammary node irradiation for the present breast cancer;
  • Patients with positive or suspicious internal mammary nodes identified by sentinel node technique which have not been irradiated or will not be irradiated, or patients with supraclavicular lymph node involvement (confirmed by fine needle aspirate or biopsy);
  • Prior use of anti-HER2 therapy for any reason or other prior biologic or immunotherapy for breast cancer;
  • Concurrent anti-cancer treatment, except hormonal therapy or radiotherapy for the present breast cancer;
  • Concurrent anti-cancer treatment in another investigational trial with hormone therapy or immunotherapy unless approved by the Executive Committee:
  • Serious cardiac illness or medical conditions including but not confined to:

History of documented congestive heart failure (CHF) or systolic dysfunction (LVEF <50%); High-risk uncontrolled arrhythmias (ventricular tachycardia, high-grade AV-block, supraventricular arrhythmias which are not adequately rate-controlled); Angina pectoris requiring antianginal medication; Clinically significant valvular heart disease; Evidence of transmural infarction on ECG; Poorly controlled hypertension (e.g. systolic >180mm Hg or diastolic >100mm Hg);

  • Other concurrent serious diseases that may interfere with planned treatment including severe pulmonary conditions/illness;
  • Any of the following abnormal laboratory tests immediately prior to randomization:

serum total bilirubin >1.5 x upper limit of normal (ULN), in the case of known Gilbert's syndrome, a higher serum total bilirubin (<2 X ULN) is allowed; alanine amino transferase (ALAT) or aspartate amino transferase (ASAT) >2.5 x ULN; alkaline phosphatase (ALP) > 2.5 x ULN; serum creatinine >2.0 x ULN; total white blood cell count (WBC) <2.5 x 10^9/L; absolute neutrophil count <1.5 x 10^9/L; platelets <100 x 10^9/L.

  • Unresolved or unstable serious adverse events from prior adjuvant chemotherapy or radiotherapy;
  • Malabsorption syndrome, any disease significantly affecting gastrointestinal function, or resection of the stomach or small bowel, or persons unable to swallow oral medication. Subjects with ulcerative colitis are also excluded;
  • Pregnant, lactating or women of childbearing potential without a negative pregnancy test - urine or serum - within 7 days prior to randomization, irrespective of the method of contraception used, including tubal ligation;
  • Women of childbearing potential and male participants with partners of child bearing potential, including women whose last menstrual period was <12 months ago (unless surgically sterile) who are unable or unwilling to use adequate contraceptive measures during study treatment (adequate contraceptive measures: intra-uterine device, barrier method - condoms, diaphragm - also in conjunction with spermicidal jelly, or total abstinence. Oral, injectable, or implant hormonal contraceptives are not indicated in this patient population);
  • Concomitant use of CYP3A4 inhibitors or inducers.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00490139

  Hide Study Locations
Locations
United States, Alabama
GSK Investigational Site
Mobile, Alabama, United States, 36608
United States, Alaska
GSK Investigational Site
Anchorage, Alaska, United States, 99508
GSK Investigational Site
Fairbanks, Alaska, United States, 99701
United States, Arizona
GSK Investigational Site
Phoenix, Arizona, United States, 85012
GSK Investigational Site
Scottsdale, Arizona, United States, 85259
GSK Investigational Site
Tucson, Arizona, United States, 85704
GSK Investigational Site
Tucson, Arizona, United States, 85715
United States, Arkansas
GSK Investigational Site
Jonesboro, Arkansas, United States, 72401
United States, California
GSK Investigational Site
Berkeley, California, United States, 94705
GSK Investigational Site
Burlingame, California, United States, 94010
GSK Investigational Site
Castro Valley, California, United States, 94546
GSK Investigational Site
Duarte, California, United States, 91010
GSK Investigational Site
Fairfield, California, United States, 94533
GSK Investigational Site
Fremont, California, United States, 94538
GSK Investigational Site
Fresno, California, United States, 93720
GSK Investigational Site
Glendale, California, United States, 91204
GSK Investigational Site
Greenbrae, California, United States, 94904
GSK Investigational Site
La Jolla, California, United States, 92093
GSK Investigational Site
La Jolla, California, United States, 92093-0987
GSK Investigational Site
Loma Linda, California, United States, 92534
GSK Investigational Site
Martinez, California, United States, 94553-3156
GSK Investigational Site
Marysville, California, United States, 95901
GSK Investigational Site
Monterey, California, United States, 93940
GSK Investigational Site
Mountain View, California, United States, 94040
GSK Investigational Site
Murrieta, California, United States, 92562
GSK Investigational Site
Oakland, California, United States, 94602
GSK Investigational Site
Oakland, California, United States, 94609
GSK Investigational Site
Orange, California, United States, 92868
GSK Investigational Site
Palm Springs, California, United States, 92262
GSK Investigational Site
Palo Alto, California, United States, 94301
GSK Investigational Site
Pismo Beach, California, United States, 93449
GSK Investigational Site
Pleasanton, California, United States, 94588
GSK Investigational Site
Sacramento, California, United States, 95817
GSK Investigational Site
San Francisco, California, United States, 94115
GSK Investigational Site
San Francisco, California, United States, 94118
GSK Investigational Site
San Francisco, California, United States, 94110
GSK Investigational Site
San Leandro, California, United States, 94578
GSK Investigational Site
Vallejo, California, United States, 94589
United States, Colorado
GSK Investigational Site
Aurora, Colorado, United States, 80012
GSK Investigational Site
Boulder, Colorado, United States, 80301
GSK Investigational Site
Colorado Springs, Colorado, United States, 80907
GSK Investigational Site
Denver, Colorado, United States, 80220
GSK Investigational Site
Denver, Colorado, United States, 80218
GSK Investigational Site
Denver, Colorado, United States, 80204
GSK Investigational Site
Denver, Colorado, United States, 80217-3364
GSK Investigational Site
Denver, Colorado, United States, 80224
GSK Investigational Site
Denver, Colorado, United States, 80210
GSK Investigational Site
Edwards, Colorado, United States, 81632
GSK Investigational Site
Englewood, Colorado, United States, 80110
GSK Investigational Site
Fort Collins, Colorado, United States, 80524
GSK Investigational Site
Ft. Collins, Colorado, United States, 80528
GSK Investigational Site
Glenwood Springs, Colorado, United States, 81601
GSK Investigational Site
Grand Junction, Colorado, United States, 81502
GSK Investigational Site
Greeley, Colorado, United States, 80631
GSK Investigational Site
Lone Tree, Colorado, United States, 80124
GSK Investigational Site
Longmont, Colorado, United States, 80502
GSK Investigational Site
Loveland, Colorado, United States, 80539
GSK Investigational Site
Montrose, Colorado, United States, 81401
GSK Investigational Site
Pueblo, Colorado, United States, 81004
GSK Investigational Site
Thornton, Colorado, United States, 80229
GSK Investigational Site
Wheat Ridge, Colorado, United States, 80033
United States, Connecticut
GSK Investigational Site
Hartford, Connecticut, United States, 06105
GSK Investigational Site
New Haven, Connecticut, United States, 06520
GSK Investigational Site
Stamford, Connecticut, United States, 06904
GSK Investigational Site
Torrington, Connecticut, United States, 06790
United States, Delaware
GSK Investigational Site
Dover, Delaware, United States, 19901
GSK Investigational Site
Milford, Delaware, United States, 19963
United States, District of Columbia
GSK Investigational Site
Washington, District of Columbia, United States, 20307
GSK Investigational Site
Washington, District of Columbia, United States, 20007
United States, Florida
GSK Investigational Site
Boca Raton, Florida, United States, 33486
GSK Investigational Site
Fort Fauderdale, Florida, United States, 33308
GSK Investigational Site
Fort Myers, Florida, United States, 33916
GSK Investigational Site
Hollywood, Florida, United States, 33021
GSK Investigational Site
Jacksonville, Florida, United States, 32207
GSK Investigational Site
Jacksonville, Florida, United States, 32224
GSK Investigational Site
Jupiter, Florida, United States, 33458
GSK Investigational Site
Lakeland, Florida, United States, 33805
GSK Investigational Site
Miami Beach, Florida, United States, 33140
GSK Investigational Site
New Port Richey, Florida, United States, 34655
GSK Investigational Site
Ocala, Florida, United States, 34471
GSK Investigational Site
Orange Park, Florida, United States, 32073
GSK Investigational Site
Orlando, Florida, United States, 32806
GSK Investigational Site
Orlando, Florida, United States, 32803
GSK Investigational Site
Titusville, Florida, United States, 32796
GSK Investigational Site
Weston, Florida, United States, 33331
United States, Georgia
GSK Investigational Site
Athens, Georgia, United States, 30607
GSK Investigational Site
Atlanta, Georgia, United States, 30342
GSK Investigational Site
Atlanta, Georgia, United States, 30309
GSK Investigational Site
Augusta, Georgia, United States, 30912
GSK Investigational Site
Augusta, Georgia, United States, 30901
GSK Investigational Site
Austell, Georgia, United States, 30106
GSK Investigational Site
Columbus, Georgia, United States, 31904
GSK Investigational Site
Decatur, Georgia, United States, 30033
GSK Investigational Site
Fort Gordon, Georgia, United States, 30905-5650
GSK Investigational Site
Gainesville, Georgia, United States, 30501
GSK Investigational Site
Lawrenceville, Georgia, United States, 30045
GSK Investigational Site
Marietta, Georgia, United States, 30060
GSK Investigational Site
Riverdale, Georgia, United States, 30274
GSK Investigational Site
Rome, Georgia, United States, 30165
GSK Investigational Site
Savannah, Georgia, United States, 31405
GSK Investigational Site
Valdosta, Georgia, United States, 31603
United States, Hawaii
GSK Investigational Site
Aiea, Hawaii, United States, 96701
GSK Investigational Site
Honolulu, Hawaii, United States, 96813
GSK Investigational Site
Honolulu, Hawaii, United States, 96817
GSK Investigational Site
Honolulu, Hawaii, United States, 96859
GSK Investigational Site
Honolulu, Hawaii, United States, 96826
GSK Investigational Site
Lihue, Hawaii, United States, 96766
GSK Investigational Site
Wailuku, Hawaii, United States, 96793
United States, Idaho
GSK Investigational Site
Boise, Idaho, United States, 83706
GSK Investigational Site
Boise, Idaho, United States, 83712
United States, Illinois
GSK Investigational Site
Alton, Illinois, United States, 62002
GSK Investigational Site
Aurora, Illinois, United States, 60504
GSK Investigational Site
Berwyn, Illinois, United States, 60402
GSK Investigational Site
Bloomington, Illinois, United States, 61701
GSK Investigational Site
Canton, Illinois, United States, 61520
GSK Investigational Site
Carthage, Illinois, United States, 62321
GSK Investigational Site
Chicago, Illinois, United States, 60611
GSK Investigational Site
Chicago, Illinois, United States, 60657
GSK Investigational Site
Eureka, Illinois, United States, 61530
GSK Investigational Site
Evanston, Illinois, United States, 60201
GSK Investigational Site
Galesburg, Illinois, United States, 61401
GSK Investigational Site
Harvey, Illinois, United States, 60426
GSK Investigational Site
Havana, Illinois, United States, 62644
GSK Investigational Site
Highland Park, Illinois, United States, 60035
GSK Investigational Site
Hopedale, Illinois, United States, 61747
GSK Investigational Site
Joliet, Illinois, United States, 60435
GSK Investigational Site
Joliet, Illinois, United States, 60432
GSK Investigational Site
Kankakee, Illinois, United States, 60901
GSK Investigational Site
Kewanee, Illinois, United States, 61443
GSK Investigational Site
La Grange, Illinois, United States, 60525
GSK Investigational Site
Libertyville, Illinois, United States, 60048
GSK Investigational Site
Macomb, Illinois, United States, 61455
GSK Investigational Site
Maywood, Illinois, United States, 60153
GSK Investigational Site
Moline, Illinois, United States, 61265
GSK Investigational Site
Monmouth, Illinois, United States, 61462
GSK Investigational Site
Mt. Vernon, Illinois, United States, 62864
GSK Investigational Site
Naperville, Illinois, United States, 60563
GSK Investigational Site
Niles, Illinois, United States, 60714
GSK Investigational Site
Normal, Illinois, United States, 61761
GSK Investigational Site
Oak Lawn, Illinois, United States, 60453-2699
GSK Investigational Site
Ottawa, Illinois, United States, 61350
GSK Investigational Site
Park Ridge, Illinois, United States, 60068
GSK Investigational Site
Pekin, Illinois, United States, 61603
GSK Investigational Site
Pekin, Illinois, United States, 61554
GSK Investigational Site
Peoria, Illinois, United States, 61637
GSK Investigational Site
Peoria, Illinois, United States, 61603
GSK Investigational Site
Peoria, Illinois, United States, 61614
GSK Investigational Site
Peoria, Illinois, United States, 61615
GSK Investigational Site
Peru, Illinois, United States, 61354
GSK Investigational Site
Princeton, Illinois, United States, 61356
GSK Investigational Site
Rockford, Illinois, United States, 61104
GSK Investigational Site
Skokie, Illinois, United States, 60077
GSK Investigational Site
Spring Valley, Illinois, United States, 61362
GSK Investigational Site
Springfield, Illinois, United States, 62781-0001
GSK Investigational Site
Urbana, Illinois, United States, 61801
GSK Investigational Site
Warrenville, Illinois, United States, 60555
GSK Investigational Site
Winfield, Illinois, United States, 60190
United States, Indiana
GSK Investigational Site
Beech Grove, Indiana, United States, 46107
GSK Investigational Site
Elkhart, Indiana, United States, 46515
GSK Investigational Site
Fort Wayne, Indiana, United States, 46815
GSK Investigational Site
Indianapolis, Indiana, United States, 46260
GSK Investigational Site
Indianapolis, Indiana, United States, 46202
GSK Investigational Site
Kokomo, Indiana, United States, 46904
GSK Investigational Site
La Porte, Indiana, United States, 46350
GSK Investigational Site
Michigan city, Indiana, United States, 46360
GSK Investigational Site
Muncie, Indiana, United States, 47303
GSK Investigational Site
Richmond, Indiana, United States, 47374
GSK Investigational Site
South Bend, Indiana, United States, 46601
GSK Investigational Site
South Bend, Indiana, United States, 46617
United States, Iowa
GSK Investigational Site
Ames, Iowa, United States, 50010
GSK Investigational Site
Bettendorf, Iowa, United States, 52722
GSK Investigational Site
Cedar Rapids, Iowa, United States, 52403
GSK Investigational Site
Cedar Rapids, Iowa, United States, 52402
GSK Investigational Site
Des Moines, Iowa, United States, 50307
GSK Investigational Site
Des Moines, Iowa, United States, 50309
GSK Investigational Site
Des Moines, Iowa, United States, 50314
GSK Investigational Site
Des Moines, Iowa, United States, 50316
GSK Investigational Site
Mason City, Iowa, United States
GSK Investigational Site
Ottumwa, Iowa, United States, 52501
GSK Investigational Site
Sioux City, Iowa, United States, 51104
GSK Investigational Site
Sioux City, Iowa, United States, 51101-1733
GSK Investigational Site
Waterloo, Iowa, United States, 50701
GSK Investigational Site
Waterloo, Iowa, United States, 50702
United States, Kansas
GSK Investigational Site
Anthony, Kansas, United States, 67003
GSK Investigational Site
Chanute, Kansas, United States, 66720
GSK Investigational Site
Dodge City, Kansas, United States, 67801
GSK Investigational Site
El Dorado, Kansas, United States, 67042
GSK Investigational Site
Fort Scott, Kansas, United States, 66701
GSK Investigational Site
Independence, Kansas, United States, 67301
GSK Investigational Site
Kansas City, Kansas, United States, 66160
GSK Investigational Site
Kingman, Kansas, United States, 67068
GSK Investigational Site
Lawrence, Kansas, United States, 66044
GSK Investigational Site
Liberal, Kansas, United States, 67901
GSK Investigational Site
Newton, Kansas, United States, 67114
GSK Investigational Site
Olathe, Kansas, United States, 66061
GSK Investigational Site
Overland Park, Kansas, United States, 66209
GSK Investigational Site
Overland Park, Kansas, United States, 66213
GSK Investigational Site
Overland Park, Kansas, United States, 66210
GSK Investigational Site
Parsons, Kansas, United States, 67357
GSK Investigational Site
Prairie Village, Kansas, United States, 66208
GSK Investigational Site
Pratt, Kansas, United States, 67124
GSK Investigational Site
Salina, Kansas, United States, 67042
GSK Investigational Site
Shawnee Mission, Kansas, United States, 66204
GSK Investigational Site
Topeka, Kansas, United States, 66606
GSK Investigational Site
Topeka, Kansas, United States, 66604
GSK Investigational Site
Wellington, Kansas, United States, 67152
GSK Investigational Site
Wichita, Kansas, United States, 67203
GSK Investigational Site
Wichita, Kansas, United States, 67208
GSK Investigational Site
Wichita, Kansas, United States, 67214
GSK Investigational Site
Winfield, Kansas, United States, 67156
United States, Kentucky
GSK Investigational Site
Louisville, Kentucky, United States, 40292
United States, Louisiana
GSK Investigational Site
Baton Rouge, Louisiana, United States, 70809
GSK Investigational Site
Baton Rouge, Louisiana, United States, 70806
GSK Investigational Site
Houma, Louisiana, United States, 70360
GSK Investigational Site
New Orleans, Louisiana, United States, 70112
GSK Investigational Site
New Orleans, Louisiana, United States, 70121
United States, Maine
GSK Investigational Site
Portland, Maine, United States, 04101
GSK Investigational Site
Scarborough, Maine, United States, 04074
United States, Maryland
GSK Investigational Site
Baltimore, Maryland, United States, 21201
GSK Investigational Site
Baltimore, Maryland, United States, 21287-8936
GSK Investigational Site
Bethesda, Maryland, United States, 20889-5600
GSK Investigational Site
Easton, Maryland, United States, 21601
GSK Investigational Site
Frederick, Maryland, United States, 21701
GSK Investigational Site
Hagerstown, Maryland, United States, 21740
GSK Investigational Site
Silver Spring, Maryland, United States, 20910
GSK Investigational Site
Towson, Maryland, United States, 21204
GSK Investigational Site
Westminster, Maryland, United States, 21157
United States, Massachusetts
GSK Investigational Site
Boston, Massachusetts, United States, 02114
GSK Investigational Site
Boston, Massachusetts, United States, 02135
GSK Investigational Site
Boston, Massachusetts, United States, 02215
GSK Investigational Site
Boston, Massachusetts, United States, 02115
GSK Investigational Site
Burlington, Massachusetts, United States, 01805
GSK Investigational Site
Gloucester, Massachusetts, United States, 01930
GSK Investigational Site
Hyannis, Massachusetts, United States, 02601
GSK Investigational Site
Lowell, Massachusetts, United States
GSK Investigational Site
Peabody, Massachusetts, United States, 01960
United States, Michigan
GSK Investigational Site
Adrian, Michigan, United States, 49221
GSK Investigational Site
Ann Arbor, Michigan, United States, 48109
GSK Investigational Site
Ann Arbor, Michigan, United States, 48106
GSK Investigational Site
Ann Arbor, Michigan, United States, 48106-0995
GSK Investigational Site
Battle Creek, Michigan, United States, 49016
GSK Investigational Site
Big Rapids, Michigan, United States
GSK Investigational Site
Byron Center, Michigan, United States, 49519
GSK Investigational Site
Dearborn, Michigan, United States, 48123
GSK Investigational Site
Detroit, Michigan, United States, 48236
GSK Investigational Site
Detroit, Michigan, United States, 48202
GSK Investigational Site
Escanaba, Michigan, United States, 49431
GSK Investigational Site
Flint, Michigan, United States, 48502
GSK Investigational Site
Flint, Michigan, United States, 48532
GSK Investigational Site
Grand Rapids, Michigan, United States, 49503
GSK Investigational Site
Iron Mountain, Michigan, United States, 49801
GSK Investigational Site
Jackson, Michigan, United States, 49201
GSK Investigational Site
Kalamazoo, Michigan, United States, 49007
GSK Investigational Site
Kalamazoo, Michigan, United States, 49001
GSK Investigational Site
Lansing, Michigan, United States, 48912
GSK Investigational Site
Livonia, Michigan, United States, 48154
GSK Investigational Site
Monroe, Michigan, United States, 48162
GSK Investigational Site
Muskegon, Michigan, United States, 49444
GSK Investigational Site
Pontiac, Michigan, United States, 48341-2985
GSK Investigational Site
Port Huron, Michigan, United States, 48060
GSK Investigational Site
Saginaw, Michigan, United States, 48601
GSK Investigational Site
Southfield, Michigan, United States, 48075
GSK Investigational Site
St. Joseph, Michigan, United States
GSK Investigational Site
St. Joseph, Michigan, United States, 49085
GSK Investigational Site
Traverse City, Michigan, United States, 49684
GSK Investigational Site
Warren, Michigan, United States, 48093
United States, Minnesota
GSK Investigational Site
Albert Lea, Minnesota, United States, 56007
GSK Investigational Site
Alexandria, Minnesota, United States, 56308
GSK Investigational Site
Bemidhi, Minnesota, United States, 56601
GSK Investigational Site
Burnsville, Minnesota, United States, 55337
GSK Investigational Site
Coon Rapids, Minnesota, United States, 55433
GSK Investigational Site
Duluth, Minnesota, United States, 55805
GSK Investigational Site
Edina, Minnesota, United States, 55435
GSK Investigational Site
Fergus Falls, Minnesota, United States, 56537
GSK Investigational Site
Fridley, Minnesota, United States, 55432
GSK Investigational Site
Hutchinson, Minnesota, United States, 55350
GSK Investigational Site
Litchfield, Minnesota, United States, 55355
GSK Investigational Site
Mankato, Minnesota, United States, 56002
GSK Investigational Site
Maplewood, Minnesota, United States, 55109
GSK Investigational Site
Minneapolis, Minnesota, United States, 55407-3799
GSK Investigational Site
Minneapolis, Minnesota, United States, 55415
GSK Investigational Site
Minneapolis, Minnesota, United States, 55455
GSK Investigational Site
Robbinsdale, Minnesota, United States, 55422
GSK Investigational Site
Rochester, Minnesota, United States, 55905
GSK Investigational Site
Saint Cloud, Minnesota, United States, 56303
GSK Investigational Site
Saint Paul, Minnesota, United States, 55102
GSK Investigational Site
Saint Paul, Minnesota, United States, 55101
GSK Investigational Site
Shakopee, Minnesota, United States, 55379
GSK Investigational Site
St Paul, Minnesota, United States, 55102
GSK Investigational Site
St. Louis Park, Minnesota, United States, 55416
GSK Investigational Site
Waconia, Minnesota, United States, 55387
GSK Investigational Site
Willmar, Minnesota, United States, 56201
GSK Investigational Site
Woodbury, Minnesota, United States, 55125
United States, Mississippi
GSK Investigational Site
Jackson, Mississippi, United States, 39216-4505
GSK Investigational Site
Keesler AFB, Mississippi, United States, 39534
GSK Investigational Site
Pascagoula, Mississippi, United States, 39581
United States, Missouri
GSK Investigational Site
Bolivar, Missouri, United States, 65613
GSK Investigational Site
Cape Girardeau, Missouri, United States, 63701
GSK Investigational Site
Cape Girardeau, Missouri, United States, 63703
GSK Investigational Site
Independence, Missouri, United States, 64050
GSK Investigational Site
Joplin, Missouri, United States, 64804
GSK Investigational Site
Kansas City, Missouri, United States, 64111
GSK Investigational Site
Kansas City, Missouri, United States, 64131
GSK Investigational Site
Kansas City, Missouri, United States, 64116
GSK Investigational Site
Kansas City, Missouri, United States, 64114
GSK Investigational Site
Kansas City, Missouri, United States, 64108
GSK Investigational Site
Kansas City, Missouri, United States, 64118
GSK Investigational Site
Kansas City, Missouri, United States, 64132
GSK Investigational Site
Kansas City, Missouri, United States, 64154
GSK Investigational Site
Lee's Summit, Missouri, United States, 64086
GSK Investigational Site
Liberty, Missouri, United States, 64068
GSK Investigational Site
Saint Joseph, Missouri, United States, 64506
GSK Investigational Site
Saint Jospeh, Missouri, United States, 64507
GSK Investigational Site
Saint Louis, Missouri, United States, 63109
GSK Investigational Site
Saint Louis, Missouri, United States, 63131
GSK Investigational Site
Springfield, Missouri, United States, 65807
GSK Investigational Site
Springfield, Missouri, United States, 65802
GSK Investigational Site
Springfield, Missouri, United States, 65804
GSK Investigational Site
St Louis, Missouri, United States, 63141
GSK Investigational Site
St. Louis, Missouri, United States, 63110
GSK Investigational Site
St. Louis, Missouri, United States, 63141
United States, Montana
GSK Investigational Site
Billings, Montana, United States, 59101
GSK Investigational Site
Bozeman, Montana, United States, 59715
GSK Investigational Site
Butte, Montana, United States, 59701
GSK Investigational Site
Great Falls, Montana, United States, 59405
GSK Investigational Site
Havre, Montana, United States, 59501
GSK Investigational Site
Helena, Montana, United States, 59601
GSK Investigational Site
Kalispell, Montana, United States, 59901
GSK Investigational Site
Missoula, Montana, United States, 59801
GSK Investigational Site
Missoula, Montana, United States, 59804
GSK Investigational Site
Missoula, Montana, United States, 59802
United States, Nebraska
GSK Investigational Site
Grand Island, Nebraska, United States, 68803
GSK Investigational Site
Lincoln, Nebraska, United States, 68510
GSK Investigational Site
Omaha, Nebraska, United States, 68198
GSK Investigational Site
Omaha, Nebraska, United States, 68114
GSK Investigational Site
Omaha, Nebraska, United States, 68131
GSK Investigational Site
Omaha, Nebraska, United States, 68106
GSK Investigational Site
Omaha, Nebraska, United States, 68124
GSK Investigational Site
Omaha, Nebraska, United States, 68122
United States, Nevada
GSK Investigational Site
Las Vegas, Nevada, United States, 89169
United States, New Hampshire
GSK Investigational Site
Concord, New Hampshire, United States, 03301
GSK Investigational Site
Exeter, New Hampshire, United States, 03833
GSK Investigational Site
Hooksett, New Hampshire, United States, 03106
GSK Investigational Site
Keene, New Hampshire, United States, 03431
GSK Investigational Site
Laconia, New Hampshire, United States, 03246
GSK Investigational Site
Lebanon, New Hampshire, United States, 03756
GSK Investigational Site
Manchester, New Hampshire, United States, 03104
GSK Investigational Site
Portsmouth, New Hampshire, United States, 03802
United States, New Jersey
GSK Investigational Site
Hackensack, New Jersey, United States, 07601
GSK Investigational Site
Hamilton, New Jersey, United States, 08690
GSK Investigational Site
Livingston, New Jersey, United States, 07039
GSK Investigational Site
Marlton, New Jersey, United States, 08053
GSK Investigational Site
Morristown, New Jersey, United States, 07962
GSK Investigational Site
Mount Holly, New Jersey, United States, 08060
GSK Investigational Site
Neptune, New Jersey, United States, 7754
GSK Investigational Site
New Brunswick, New Jersey, United States, 08901
GSK Investigational Site
Pomona, New Jersey, United States, 08240
GSK Investigational Site
Princeton, New Jersey, United States, 24740
GSK Investigational Site
Ridgewood, New Jersey, United States, 07450
GSK Investigational Site
Somerville, New Jersey, United States, 08876
GSK Investigational Site
Sparta, New Jersey, United States, 07871
GSK Investigational Site
Summit, New Jersey, United States, 07902
GSK Investigational Site
Vineland, New Jersey, United States, 08360
GSK Investigational Site
Voorhees, New Jersey, United States, 08043
United States, New Mexico
GSK Investigational Site
Albuquerque, New Mexico, United States, 87106
GSK Investigational Site
Albuquerque, New Mexico, United States, 87110
GSK Investigational Site
Las Cruces, New Mexico, United States, 88011
United States, New York
GSK Investigational Site
Bronx, New York, United States, 10467-2490
GSK Investigational Site
Bronx, New York, United States, 10466
GSK Investigational Site
Bronx, New York, United States, 10461
GSK Investigational Site
Buffalo, New York, United States, 14263
GSK Investigational Site
Clifton Springs, New York, United States, 14432
GSK Investigational Site
Cooperstown, New York, United States, 13326
GSK Investigational Site
East Syracuse, New York, United States, 13057
GSK Investigational Site
Elmhurst, New York, United States, 11373
GSK Investigational Site
Jamaica, New York, United States, 11432
GSK Investigational Site
Lake Success, New York, United States, 11042
GSK Investigational Site
Manhasset, New York, United States, 11030
GSK Investigational Site
Mineola, New York, United States, 11501
GSK Investigational Site
New Hyde Park, New York, United States, 11042
GSK Investigational Site
New York, New York, United States, 10032
GSK Investigational Site
New York, New York, United States, 10029
GSK Investigational Site
New York, New York, United States, 10011
GSK Investigational Site
New York, New York, United States, 10016
GSK Investigational Site
Rochester, New York, United States, 14620
GSK Investigational Site
Rochester, New York, United States, 14642
GSK Investigational Site
Rochester, New York, United States, 14623
GSK Investigational Site
Stony Brook, New York, United States, 11794
GSK Investigational Site
Syracuse, New York, United States, 13210
GSK Investigational Site
Utica, New York, United States, 13502
United States, North Carolina
GSK Investigational Site
Chapel Hill, North Carolina, United States, 27599
GSK Investigational Site
Fayetteville, North Carolina, United States, 28304
GSK Investigational Site
Gastonia, North Carolina, United States, 28053
GSK Investigational Site
Goldsboro, North Carolina, United States, 27534
GSK Investigational Site
Hendersonville, North Carolina, United States, 28791
GSK Investigational Site
Kinston, North Carolina, United States, 28501
GSK Investigational Site
Raleigh, North Carolina, United States, 27607
GSK Investigational Site
Rutherfordton, North Carolina, United States, 28139
GSK Investigational Site
Statesville, North Carolina, United States, 28677
GSK Investigational Site
Washington, North Carolina, United States, 27889
GSK Investigational Site
Winston-Salem, North Carolina, United States, 27157
United States, North Dakota
GSK Investigational Site
Bismarck, North Dakota, United States, 58501
GSK Investigational Site
Fargo, North Dakota, United States, 58122
GSK Investigational Site
Grand Forks, North Dakota, United States, 58201
GSK Investigational Site
Minot, North Dakota, United States, 58701
United States, Ohio
GSK Investigational Site
Beachwood, Ohio, United States, 44122
GSK Investigational Site
Bellefontaine, Ohio, United States, 43311
GSK Investigational Site
Bowling Green, Ohio, United States, 43402
GSK Investigational Site
Canton, Ohio, United States, 44708
GSK Investigational Site
Canton, Ohio, United States, 44710
GSK Investigational Site
Chillicothe, Ohio, United States, 54601
GSK Investigational Site
Cincinnati, Ohio, United States, 45267
GSK Investigational Site
Cincinnati, Ohio, United States, 45242
GSK Investigational Site
Cleveland, Ohio, United States, 44195
GSK Investigational Site
Cleveland, Ohio, United States, 44111
GSK Investigational Site
Clyde, Ohio, United States, 43410
GSK Investigational Site
Columbia, Ohio, United States, 43215
GSK Investigational Site
Columbus, Ohio, United States, 43215
GSK Investigational Site
Columbus, Ohio, United States, 43210
GSK Investigational Site
Columbus, Ohio, United States, 43214
GSK Investigational Site
Columbus, Ohio, United States, 43222
GSK Investigational Site
Columbus, Ohio, United States, 43228
GSK Investigational Site
Dayton, Ohio, United States, 45429
GSK Investigational Site
Dayton, Ohio, United States, 45406
GSK Investigational Site
Dayton, Ohio, United States, 45409
GSK Investigational Site
Dayton, Ohio, United States, 45415
GSK Investigational Site
Dayton, Ohio, United States, 45405
GSK Investigational Site
Deleware, Ohio, United States, 43015
GSK Investigational Site
Elyria, Ohio, United States, 44035
GSK Investigational Site
Findlay, Ohio, United States, 45840
GSK Investigational Site
Franklin, Ohio, United States, 45005-1066
GSK Investigational Site
Greenville, Ohio, United States, 45331
GSK Investigational Site
Independence, Ohio, United States, 44131
GSK Investigational Site
Kettering, Ohio, United States, 45429
GSK Investigational Site
Lambertville, Ohio, United States, 48144
GSK Investigational Site
Lima, Ohio, United States, 45804
GSK Investigational Site
Marietta, Ohio, United States, 45750
GSK Investigational Site
Maumee, Ohio, United States, 43623
GSK Investigational Site
Maumee, Ohio, United States, 43537
GSK Investigational Site
Mayfield Heights, Ohio, United States, 44124
GSK Investigational Site
Newark, Ohio, United States, 43055
GSK Investigational Site
Oregon, Ohio, United States, 43616
GSK Investigational Site
Sandusky, Ohio, United States, 44870
GSK Investigational Site
Springfield, Ohio, United States, 45504
GSK Investigational Site
Springfield, Ohio, United States, 45505
GSK Investigational Site
Sylvania, Ohio, United States, 43560
GSK Investigational Site
Tiffin, Ohio, United States, 44883
GSK Investigational Site
Toledo, Ohio, United States, 43617
GSK Investigational Site
Toledo, Ohio, United States, 43614
GSK Investigational Site
Toledo, Ohio, United States, 43608
GSK Investigational Site
Toledo, Ohio, United States, 43606
GSK Investigational Site
Toledo, Ohio, United States, 43623
GSK Investigational Site
Troy, Ohio, United States, 45373
GSK Investigational Site
Wauseon, Ohio, United States, 43567
GSK Investigational Site
Westerville, Ohio, United States, 43081
GSK Investigational Site
Wilmington, Ohio, United States, 45177
GSK Investigational Site
Wooster, Ohio, United States, 44691
GSK Investigational Site
Wpafb, Ohio, United States, 45433
GSK Investigational Site
Xenia, Ohio, United States, 45385
GSK Investigational Site
Zanesville, Ohio, United States, 43701
United States, Oklahoma
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73120
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73112
GSK Investigational Site
Oklahoma City, Oklahoma, United States, 73104
GSK Investigational Site
Tulsa, Oklahoma, United States, 74136
United States, Oregon
GSK Investigational Site
Coos Bay, Oregon, United States, 97420
GSK Investigational Site
Eugene, Oregon, United States, 97401
GSK Investigational Site
Glesham, Oregon, United States, 97030
GSK Investigational Site
Hillsboro, Oregon, United States, 97123
GSK Investigational Site
Klamath Falls, Oregon, United States, 97601
GSK Investigational Site
Milwaukie, Oregon, United States, 97222
GSK Investigational Site
Portland, Oregon, United States, 97216
GSK Investigational Site
Portland, Oregon, United States, 97227
GSK Investigational Site
Portland, Oregon, United States, 97225
GSK Investigational Site
Portland, Oregon, United States, 97239
GSK Investigational Site
Portland, Oregon, United States, 97213
GSK Investigational Site
Portland, Oregon, United States, 97210
GSK Investigational Site
Tualatin, Oregon, United States, 97062
United States, Pennsylvania
GSK Investigational Site
Abington, Pennsylvania, United States, 19001-3788
GSK Investigational Site
Bethlehem, Pennsylvania, United States, 18015
GSK Investigational Site
Bryn Mawr, Pennsylvania, United States, 19010
GSK Investigational Site
Butler, Pennsylvania, United States, 16001
GSK Investigational Site
Danville, Pennsylvania, United States, 17822-2001
GSK Investigational Site
Ephrata, Pennsylvania, United States, 17522
GSK Investigational Site
Hazelton, Pennsylvania, United States, 18201
GSK Investigational Site
Hershey, Pennsylvania, United States, 17033
GSK Investigational Site
Kingston, Pennsylvania, United States, 18704
GSK Investigational Site
Lancaster, Pennsylvania, United States, 17604
GSK Investigational Site
Langhorne, Pennsylvania, United States, 19047
GSK Investigational Site
Lewistown, Pennsylvania, United States, 17044
GSK Investigational Site
Media, Pennsylvania, United States, 19063
GSK Investigational Site
Nashville, Pennsylvania, United States, 37204
GSK Investigational Site
Paoli, Pennsylvania, United States, 19301
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19114
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19111
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19107
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19107-2568
GSK Investigational Site
Phoenixville, Pennsylvania, United States, 19460
GSK Investigational Site
Pottstown, Pennsylvania, United States, 19464
GSK Investigational Site
Sayre, Pennsylvania, United States, 18840
GSK Investigational Site
Scranton, Pennsylvania, United States, 18508
GSK Investigational Site
Sellersville, Pennsylvania, United States, 18960
GSK Investigational Site
State College, Pennsylvania, United States, 16801
GSK Investigational Site
State College, Pennsylvania, United States, 16803
GSK Investigational Site
West Reading, Pennsylvania, United States, 19612
GSK Investigational Site
Wilkes-Barre, Pennsylvania, United States, 18711
GSK Investigational Site
Wilkes-Barre, Pennsylvania, United States, 18765
GSK Investigational Site
Wynnewood, Pennsylvania, United States, 19096
United States, Rhode Island
GSK Investigational Site
Providence, Rhode Island, United States, 02903
GSK Investigational Site
Providence, Rhode Island, United States, 02906
GSK Investigational Site
Providence, Rhode Island, United States, 02905
GSK Investigational Site
Warwick, Rhode Island, United States, 02886
United States, South Carolina
GSK Investigational Site
Anderson, South Carolina, United States, 29621
GSK Investigational Site
Charleston, South Carolina, United States, 29425
GSK Investigational Site
Columbia, South Carolina, United States, 29210
GSK Investigational Site
Greenville, South Carolina, United States, 29605
GSK Investigational Site
Mt. Pleasant, South Carolina, United States, 29464
GSK Investigational Site
Spartanburg, South Carolina, United States, 29303
United States, South Dakota
GSK Investigational Site
Aberdeen, South Dakota, United States, 57401
GSK Investigational Site
Rapid City, South Dakota, United States, 57701
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57104
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57105
GSK Investigational Site
Sioux Falls, South Dakota, United States, 57117-5134
United States, Tennessee
GSK Investigational Site
Chattanooga, Tennessee, United States, 37404
GSK Investigational Site
Chattanooga, Tennessee, United States, 37403
GSK Investigational Site
Franklin, Tennessee, United States, 37067
GSK Investigational Site
Jackson, Tennessee, United States, 38301
GSK Investigational Site
Knoxville, Tennessee, United States, 37916
GSK Investigational Site
Knoxville, Tennessee, United States, 37909
GSK Investigational Site
Knoxville, Tennessee, United States, 37920
GSK Investigational Site
Memphis, Tennessee, United States, 38120
GSK Investigational Site
Nashville, Tennessee, United States, 37232
GSK Investigational Site
Nashville, Tennessee, United States, 37208
GSK Investigational Site
Nashville, Tennessee, United States, 37203
United States, Texas
GSK Investigational Site
Abilene, Texas, United States, 79606-5208
GSK Investigational Site
Amarillo, Texas, United States, 79106
GSK Investigational Site
Austin, Texas, United States, 78731
GSK Investigational Site
Austin, Texas, United States, 78758
GSK Investigational Site
Austin, Texas, United States, 78705
GSK Investigational Site
Austin, Texas, United States, 78745
GSK Investigational Site
Beaumont, Texas, United States, 77702-1449
GSK Investigational Site
Bedford, Texas, United States, 76022
GSK Investigational Site
Cedar Park, Texas, United States, 78613
GSK Investigational Site
Dallas, Texas, United States, 75237
GSK Investigational Site
Dallas, Texas, United States, 75230
GSK Investigational Site
Fort Sam Houston, Texas, United States, 78234
GSK Investigational Site
Fort Worth, Texas, United States, 76104
GSK Investigational Site
Houston, Texas, United States, 77030
GSK Investigational Site
Lackland Air Force Base, Texas, United States, 78236
GSK Investigational Site
Longview, Texas, United States, 75601
GSK Investigational Site
McAllen, Texas, United States, 78503-1298
GSK Investigational Site
Mesquite, Texas, United States, 75150
GSK Investigational Site
Midland, Texas, United States, 79701
GSK Investigational Site
Paris, Texas, United States, 75460
GSK Investigational Site
Round Rock, Texas, United States, 78655
GSK Investigational Site
Round Rock, Texas, United States, 78681
GSK Investigational Site
San Antonio, Texas, United States, 78229
GSK Investigational Site
San Antonio, Texas, United States, 78209
GSK Investigational Site
San Marcos, Texas, United States, 78666
GSK Investigational Site
Sherman, Texas, United States, 75090
GSK Investigational Site
Sugar Land, Texas, United States, 77479
GSK Investigational Site
Tyler, Texas, United States, 75702
GSK Investigational Site
Waco, Texas, United States, 76712
GSK Investigational Site
Wichita Falls, Texas, United States, 76310
United States, Utah
GSK Investigational Site
Salt Lake City, Utah, United States, 84112
United States, Vermont
GSK Investigational Site
Berlin, Vermont, United States, 05602
GSK Investigational Site
Burlington, Vermont, United States, 05401
GSK Investigational Site
Saint Johnsbury, Vermont, United States, 05819
United States, Virginia
GSK Investigational Site
Charlottesville, Virginia, United States, 22902
GSK Investigational Site
Danville, Virginia, United States, 24541
GSK Investigational Site
Fredricksburg, Virginia, United States, 22401
GSK Investigational Site
Hampton, Virginia, United States, 23666
GSK Investigational Site
Norfolk, Virginia, United States, 23502
GSK Investigational Site
Richmond, Virginia, United States, 23230
GSK Investigational Site
Roanoke, Virginia, United States, 24014
United States, Washington
GSK Investigational Site
Auburn, Washington, United States, 98002
GSK Investigational Site
Bellingham, Washington, United States, 98225
GSK Investigational Site
Bremerton, Washington, United States, 98310
GSK Investigational Site
Burien, Washington, United States, 98166
GSK Investigational Site
Centralia, Washington, United States, 98531
GSK Investigational Site
Federal way, Washington, United States, 98003
GSK Investigational Site
Kennewick, Washington, United States, 99336
GSK Investigational Site
Kirkland, Washington, United States
GSK Investigational Site
Mount Vernon, Washington, United States, 98273
GSK Investigational Site
Olympia, Washington, United States, 98506
GSK Investigational Site
Port Angeles, Washington, United States, 98362
GSK Investigational Site
Poulsbo, Washington, United States, 98370
GSK Investigational Site
Puyallup, Washington, United States, 98372
GSK Investigational Site
Renton, Washington, United States, 98055
GSK Investigational Site
Seattle, Washington, United States, 98122
GSK Investigational Site
Seattle, Washington, United States, 98104
GSK Investigational Site
Seattle, Washington, United States, 98112
GSK Investigational Site
Seattle, Washington, United States, 98195-6098
GSK Investigational Site
Seattle, Washington, United States, 98133
GSK Investigational Site
Seattle, Washington, United States, 98122-4299
GSK Investigational Site
Spokane, Washington, United States, 99218
GSK Investigational Site
Spokane, Washington, United States, 99202
GSK Investigational Site
Tacoma, Washington, United States, 98499
GSK Investigational Site
Tacoma, Washington, United States, 98405
GSK Investigational Site
Tacoma, Washington, United States, 98415
GSK Investigational Site
Vancouver, Washington, United States, 98686
GSK Investigational Site
Vancouver, Washington, United States, 98668
GSK Investigational Site
Wenatchee, Washington, United States, 98801
United States, West Virginia
GSK Investigational Site
Charleston, West Virginia, United States, 25304
GSK Investigational Site
Huntington, West Virginia, United States, 25701
GSK Investigational Site
Wheeling, West Virginia, United States, 26003
United States, Wisconsin
GSK Investigational Site
Appleton, Wisconsin, United States, 54911
GSK Investigational Site
Chippewa Falls, Wisconsin, United States, 54729
GSK Investigational Site
Eau Claire, Wisconsin, United States, 54701
GSK Investigational Site
Eau Claire, Wisconsin, United States, 54702
GSK Investigational Site
Green Bay, Wisconsin, United States, 54301
GSK Investigational Site
Green Bay, Wisconsin, United States, 54303
GSK Investigational Site
La Crosse, Wisconsin, United States, 54601
GSK Investigational Site
Madison, Wisconsin, United States, 53717
GSK Investigational Site
Manitowoc, Wisconsin, United States, 54221
GSK Investigational Site
Marinette, Wisconsin, United States, 54143
GSK Investigational Site
Marshfield, Wisconsin, United States, 54449
GSK Investigational Site
Milwaukee, Wisconsin, United States, 53233
GSK Investigational Site
Minocqua, Wisconsin, United States, 54548
GSK Investigational Site
Oconto Falls, Wisconsin, United States, 54154
GSK Investigational Site
Oshkosh, Wisconsin, United States, 54904
GSK Investigational Site
Rhinelander, Wisconsin, United States, 54501
GSK Investigational Site
Rice Lake, Wisconsin, United States, 54868
GSK Investigational Site
Stevens Point, Wisconsin, United States, 54481
GSK Investigational Site
Sturgeon Bay, Wisconsin, United States, 54235
GSK Investigational Site
Weston, Wisconsin, United States, 54476
GSK Investigational Site
Wisconsin Rapids, Wisconsin, United States, 54494
United States, Wyoming
GSK Investigational Site
Casper, Wyoming, United States, 82609
GSK Investigational Site
Sheridan, Wyoming, United States, 82801
Argentina
GSK Investigational Site
Berazategui, Buenos Aires, Argentina, B1880BBF
GSK Investigational Site
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1185AAT
GSK Investigational Site
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina, C1125ABD
GSK Investigational Site
Rosario, Santa Fe, Argentina, S2000KZE
GSK Investigational Site
Ciudad Autónoma de Buenos Aires, Argentina, C1417DTN
GSK Investigational Site
Mendoza, Argentina, M5500AYB
GSK Investigational Site
Quilmes, Argentina, 1878
GSK Investigational Site
Santa Fe, Argentina, 3000
GSK Investigational Site
Tucuman, Argentina, 4000
Australia, New South Wales
GSK Investigational Site
Camperdown, New South Wales, Australia, 2050
GSK Investigational Site
Coffs Harbour, New South Wales, Australia, 2450
GSK Investigational Site
Concord, New South Wales, Australia, 2139
GSK Investigational Site
Kingswood, New South Wales, Australia, 2747
GSK Investigational Site
Lismore, New South Wales, Australia, 2480
GSK Investigational Site
Liverpool, New South Wales, Australia, 2170
GSK Investigational Site
North Sydney, New South Wales, Australia, 2060
GSK Investigational Site
Port Macquarie, New South Wales, Australia, 2444
GSK Investigational Site
Randwick, New South Wales, Australia, 2031
GSK Investigational Site
Taree, New South Wales, Australia, 2430
GSK Investigational Site
Tweed Heads, New South Wales, Australia, 2485
GSK Investigational Site
Wagga Wagga, New South Wales, Australia, 2650
GSK Investigational Site
Waratah, New South Wales, Australia, 2298
GSK Investigational Site
Westmead, New South Wales, Australia, 2145
Australia, Queensland
GSK Investigational Site
Nambour, Queensland, Australia, 4560
GSK Investigational Site
South Brisbane, Queensland, Australia, 4101
GSK Investigational Site
Woolloongabba, Queensland, Australia, 4102
Australia, South Australia
GSK Investigational Site
Adelaide, South Australia, Australia, 5000
GSK Investigational Site
Bedford Park, South Australia, Australia, 5042
GSK Investigational Site
Woodville, South Australia, Australia, 5011
Australia, Tasmania
GSK Investigational Site
Hobart, Tasmania, Australia, 7000
Australia, Victoria
GSK Investigational Site
Box Hill, Victoria, Australia, 3128
GSK Investigational Site
East Bentleigh, Victoria, Australia, 3165
GSK Investigational Site
East Melbourne, Victoria, Australia, 3002
GSK Investigational Site
Fitzroy, Victoria, Australia, 3065
GSK Investigational Site
Footscray, Victoria, Australia, 3011
GSK Investigational Site
Frankston, Victoria, Australia, 3199
GSK Investigational Site
Heidelberg, Victoria, Australia, 3084
GSK Investigational Site
Melbourne, Victoria, Australia, 3002
GSK Investigational Site
Parkville, Victoria, Australia, 3050
GSK Investigational Site
Ringwood East, Victoria, Australia, 3135
GSK Investigational Site
Wendouree, Victoria, Australia, 3355
Australia, Western Australia
GSK Investigational Site
Bunbury, Western Australia, Australia, 6230
GSK Investigational Site
Nedlands, Western Australia, Australia, 6009
GSK Investigational Site
Perth, Western Australia, Australia, 6001
GSK Investigational Site
Subiaco, Western Australia, Australia, 6008
Australia
GSK Investigational Site
Campbelltown, Australia, 2560
Austria
GSK Investigational Site
Guessing, Austria, 7540
GSK Investigational Site
Linz, Austria, A-4020
GSK Investigational Site
Rankweil, Austria, A-6830
GSK Investigational Site
Salzburg, Austria, A-5020
GSK Investigational Site
Steyr, Austria, 4400
GSK Investigational Site
Vienna, Austria, 1140
GSK Investigational Site
Villach, Austria, 9500
GSK Investigational Site
Wien, Austria, A-1090
Belgium
GSK Investigational Site
Aalst, Belgium, 9300
GSK Investigational Site
Antwerpen, Belgium, 2020
GSK Investigational Site
Bonheiden, Belgium, 2820
GSK Investigational Site
Brasschaat, Belgium, 2930
GSK Investigational Site
Brugge, Belgium, 8000
GSK Investigational Site
Brussel, Belgium, 1090
GSK Investigational Site
Brussels, Belgium, 1000
GSK Investigational Site
Brussels, Belgium, 1070
GSK Investigational Site
Bruxelles, Belgium, 1020
GSK Investigational Site
Bruxelles, Belgium, 1200
GSK Investigational Site
Charleroi, Belgium, 6000
GSK Investigational Site
Edegem, Belgium, 2650
GSK Investigational Site
Genk, Belgium, 3600
GSK Investigational Site
Gent, Belgium, 9000
GSK Investigational Site
Haine Saint Paul, Belgium, 7100
GSK Investigational Site
Hasselt, Belgium, 3500
GSK Investigational Site
Huy, Belgium, 4500
GSK Investigational Site
Ixelles, Belgium, 1050
GSK Investigational Site
Kortrijk, Belgium, 8500
GSK Investigational Site
Leuven, Belgium, 3000
GSK Investigational Site
Liège, Belgium, 4000
GSK Investigational Site
Mons, Belgium, 7000
GSK Investigational Site
Namur, Belgium, 5000
GSK Investigational Site
Roeselare, Belgium, 8800
GSK Investigational Site
Sint-Niklaas, Belgium, 9100
GSK Investigational Site
Tournai, Belgium, 7500
GSK Investigational Site
Turnhout, Belgium, 2300
GSK Investigational Site
Verviers, Belgium, 4800
GSK Investigational Site
Wilrijk, Belgium, 2610
GSK Investigational Site
Yvoir, Belgium, 5530
Brazil
GSK Investigational Site
Salvador, Bahía, Brazil, 40.050-410
GSK Investigational Site
Belo Horizonte, Minas Gerais, Brazil, 30150-270
GSK Investigational Site
Porte Alegre, Rio Grande Do Sul, Brazil, 90430-001
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90035-003
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90430-090
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90560-030
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90610000
GSK Investigational Site
Porto Alegre, Rio Grande Do Sul, Brazil, 90050-170
GSK Investigational Site
Jaú, São Paulo, Brazil, 17210-120
GSK Investigational Site
Santo André, São Paulo, Brazil, 09060-650
GSK Investigational Site
Rio de Janeiro, Brazil, 20560-120
Bulgaria
GSK Investigational Site
Shumen, Bulgaria, 9700
GSK Investigational Site
Sofia, Bulgaria, 1756
GSK Investigational Site
Sofia, Bulgaria, 1527
GSK Investigational Site
Varna, Bulgaria, 9010
Canada, British Columbia
GSK Investigational Site
Kelowna, British Columbia, Canada, V1Y 5L3
GSK Investigational Site
Vancouver, British Columbia, Canada, V5Z 4E6
Canada, New Brunswick
GSK Investigational Site
Moncton, New Brunswick, Canada, E1C 8X3
GSK Investigational Site
Saint John, New Brunswick, Canada, E2L 4L2
Canada, Ontario
GSK Investigational Site
Barrie, Ontario, Canada, L4M 6M2
GSK Investigational Site
London, Ontario, Canada, N6A 4L6
GSK Investigational Site
Sault Ste. Marie, Ontario, Canada, P6A 2C4
GSK Investigational Site
St Catharines, Ontario, Canada, L2R 7C6
GSK Investigational Site
Toronto, Ontario, Canada, M4N 3M5
Canada, Prince Edward Island
GSK Investigational Site
Charlottetown, Prince Edward Island, Canada, C1A 8T5
Canada, Quebec
GSK Investigational Site
Sherbrooke, Quebec, Canada, J1H 5N4
Canada, Saskatchewan
GSK Investigational Site
Regina, Saskatchewan, Canada, S4T 7T1
Chile
GSK Investigational Site
Temuco, Región De La Araucania, Chile, 481-0469
GSK Investigational Site
Valdivia, Región De Los Lagos, Chile, 5090145
GSK Investigational Site
Santiago, Región Metro De Santiago, Chile, 8360160
GSK Investigational Site
Santiago, Región Metro De Santiago, Chile, 8380455
GSK Investigational Site
Santiago, Región Metro De Santiago, Chile, 7650635
GSK Investigational Site
Santiago, Región Metro De Santiago, Chile, 7500921
GSK Investigational Site
Valparaiso, Valparaíso, Chile, 2341131
GSK Investigational Site
Viña del Mar, Valparaíso, Chile, 254-0364
GSK Investigational Site
Arica, Chile, 1000871
China, Guangdong
GSK Investigational Site
Guangzhou, Guangdong, China, 510060
China
GSK Investigational Site
Beijing, China, 100021
GSK Investigational Site
Beijing, China, 100071
GSK Investigational Site
Shanghai, China, 200032
GSK Investigational Site
Tianjin, China, 300060
Croatia
GSK Investigational Site
Varaždin, Croatia
GSK Investigational Site
Zagreb, Croatia, 10 000
GSK Investigational Site
Zagreb, Croatia, 10000
Czech Republic
GSK Investigational Site
Brno, Czech Republic, 625 00
GSK Investigational Site
Brno, Czech Republic, 656 53
GSK Investigational Site
Brno, Czech Republic, 656 91
GSK Investigational Site
Ceske Budejovice, Czech Republic, 370 87
GSK Investigational Site
Chomutov, Czech Republic, 43012
GSK Investigational Site
Jihlava, Czech Republic, 586 01
GSK Investigational Site
Novy Jicin, Czech Republic, 741 01
GSK Investigational Site
Olomouc, Czech Republic, 775 20
GSK Investigational Site
Pardubice, Czech Republic, 532 03
GSK Investigational Site
Praha 10, Czech Republic, 100 34
GSK Investigational Site
Praha 2, Czech Republic, 12808
GSK Investigational Site
Praha 4, Czech Republic, 140 59
GSK Investigational Site
Praha 5, Czech Republic, 150 08
GSK Investigational Site
Praha 8, Czech Republic, 180 00
GSK Investigational Site
Usti nad Labem, Czech Republic, 40113
Denmark
GSK Investigational Site
Aalborg, Denmark, 9100
GSK Investigational Site
Esbjerg, Denmark, 6700
GSK Investigational Site
Herlev, Denmark, DK-2730
GSK Investigational Site
Hillerød, Denmark, 3400
GSK Investigational Site
Koebenhavn Oe, Denmark, 2100
GSK Investigational Site
Naestved, Denmark, 4700
GSK Investigational Site
Odense, Denmark, 5000
GSK Investigational Site
Roskilde, Denmark, 4000
GSK Investigational Site
Vejle, Denmark, 7100
GSK Investigational Site
Viborg, Denmark, 8800
GSK Investigational Site
Århus C, Denmark, 8000
Estonia
GSK Investigational Site
Tallinn, Estonia, 13419
GSK Investigational Site
Tartu, Estonia, 51014
France
GSK Investigational Site
Angers Cedex 01, France, 49033
GSK Investigational Site
Annecy, France, 74000
GSK Investigational Site
Avignon, France, 84000
GSK Investigational Site
Bayonne, France, 64100
GSK Investigational Site
Bethune, France, 62400
GSK Investigational Site
Bordeaux, France, 33000
GSK Investigational Site
Brive La Gaillarde, France, 19100
GSK Investigational Site
Bron, France, 69677
GSK Investigational Site
Caen, France, 14000
GSK Investigational Site
Caen Cedex 05, France, 14076
GSK Investigational Site
Clermont Ferrand, France, 63000
GSK Investigational Site
Coudekerque Branche, France, 59210
GSK Investigational Site
Dijon, France, 21000
GSK Investigational Site
Dijon Cedex, France, 21079
GSK Investigational Site
Draguignan, France, 83007
GSK Investigational Site
Grenoble Cedex 1, France, 38028
GSK Investigational Site
Grenoble Cedex 9, France, 38043
GSK Investigational Site
Hyeres, France, 83400
GSK Investigational Site
La Seyne Sur Mer, France, 83500
GSK Investigational Site
Le Chesnay, France, 78157
GSK Investigational Site
Le Havre, France, 76600
GSK Investigational Site
Le Mans, France, 72000
GSK Investigational Site
Lille, France, 59000
GSK Investigational Site
Lyon, France, 69009
GSK Investigational Site
Lyon, France, 69008
GSK Investigational Site
Lyon, France, 69373
GSK Investigational Site
Marseille, France, 13285
GSK Investigational Site
Marseille Cedex 09, France, 13273
GSK Investigational Site
Marseille cedex 5, France, 13385
GSK Investigational Site
Metz cedex 01, France, 57045
GSK Investigational Site
Mont de Marsan, France, 40024
GSK Investigational Site
Montauban, France, 82000
GSK Investigational Site
Montbeliard, France, 25200
GSK Investigational Site
Mulhouse, France, 68070
GSK Investigational Site
Nancy, France, 54100
GSK Investigational Site
Nice Cedex 2, France, 06189
GSK Investigational Site
Nimes, France, 30907
GSK Investigational Site
Paris, France, 75014
GSK Investigational Site
Paris Cedex 10, France, 75475
GSK Investigational Site
Paris Cedex 5, France, 75248
GSK Investigational Site
Perigueux, France, 24004
GSK Investigational Site
Perpignan, France, 66000
GSK Investigational Site
Reims, France, 51100
GSK Investigational Site
Rouen, France, 76000
GSK Investigational Site
Rouen cedex 1, France, 76038
GSK Investigational Site
Saint Brieuc, France, 22015 cedex
GSK Investigational Site
Saint Grégoire, France, 35760
GSK Investigational Site
Saint Jean, France, 31240
GSK Investigational Site
Saint-Cloud, France, 92210
GSK Investigational Site
Saint-Herblain, France, 44805
GSK Investigational Site
Saint-Martin Boulogne, France, 62280
GSK Investigational Site
Saint-Priest en Jarez Cedex, France, 42271
GSK Investigational Site
Strasbourg, France, 67085
GSK Investigational Site
Strasbourg, France, 67000
GSK Investigational Site
Toulouse, France, 31300
GSK Investigational Site
Toulouse, France, 31077
GSK Investigational Site
Tours, France, 37044
GSK Investigational Site
Valenciennes, France, 59322
GSK Investigational Site
Vandoeuvre-Les-Nancy, France, 54511
GSK Investigational Site
Villejuif Cedex, France, 94805
Germany
GSK Investigational Site
Aalen, Baden-Wuerttemberg, Germany, 73430
GSK Investigational Site
Baden-Baden, Baden-Wuerttemberg, Germany, 76532
GSK Investigational Site
Boeblingen, Baden-Wuerttemberg, Germany, 71032
GSK Investigational Site
Emmendingen, Baden-Wuerttemberg, Germany, 79312
GSK Investigational Site
Esslingen, Baden-Wuerttemberg, Germany, 73730
GSK Investigational Site
Freiburg, Baden-Wuerttemberg, Germany, 79106
GSK Investigational Site
Goeppingen, Baden-Wuerttemberg, Germany, 73035
GSK Investigational Site
Heidelberg, Baden-Wuerttemberg, Germany, 69115
GSK Investigational Site
Heidelberg, Baden-Wuerttemberg, Germany, 69120
GSK Investigational Site
Karlsruhe, Baden-Wuerttemberg, Germany, 76199
GSK Investigational Site
Karlsruhe, Baden-Wuerttemberg, Germany, 76133
GSK Investigational Site
Karlsruhe, Baden-Wuerttemberg, Germany, 76135
GSK Investigational Site
Konstanz, Baden-Wuerttemberg, Germany, 78464
GSK Investigational Site
Loerrach, Baden-Wuerttemberg, Germany, 79539
GSK Investigational Site
Ludwigsburg, Baden-Wuerttemberg, Germany, 71640
GSK Investigational Site
Mannheim, Baden-Wuerttemberg, Germany, 68167
GSK Investigational Site
Mannheim, Baden-Wuerttemberg, Germany, 68165
GSK Investigational Site
Mutlangen, Baden-Wuerttemberg, Germany, 73557
GSK Investigational Site
Ostfildern, Baden-Wuerttemberg, Germany, 73760
GSK Investigational Site
Ravensburg, Baden-Wuerttemberg, Germany, 88212
GSK Investigational Site
Reutlingen, Baden-Wuerttemberg, Germany, 72764
GSK Investigational Site
Rheinfelden, Baden-Wuerttemberg, Germany, 79618
GSK Investigational Site
Schwaebisch Hall, Baden-Wuerttemberg, Germany, 74523
GSK Investigational Site
Schwetzingen, Baden-Wuerttemberg, Germany, 68723
GSK Investigational Site
Sigmaringen, Baden-Wuerttemberg, Germany, 72488
GSK Investigational Site
Stuttgart, Baden-Wuerttemberg, Germany, 70376
GSK Investigational Site
Stuttgart, Baden-Wuerttemberg, Germany, 70374
GSK Investigational Site
Tuebingen, Baden-Wuerttemberg, Germany, 72076
GSK Investigational Site
Tuttlingen, Baden-Wuerttemberg, Germany, 78532
GSK Investigational Site
Ulm, Baden-Wuerttemberg, Germany, 89075
GSK Investigational Site
Villingen-Schwenningen, Baden-Wuerttemberg, Germany, 78050
GSK Investigational Site
Ansbach, Bayern, Germany, 91522
GSK Investigational Site
Aschaffenburg, Bayern, Germany, 63739
GSK Investigational Site
Augsburg, Bayern, Germany, 86156
GSK Investigational Site
Bad Reichenhall, Bayern, Germany, 83435
GSK Investigational Site
Bayreuth, Bayern, Germany, 95445
GSK Investigational Site
Coburg, Bayern, Germany, 96450
GSK Investigational Site
Dachau, Bayern, Germany, 85221
GSK Investigational Site
Deggendorf, Bayern, Germany, 94469
GSK Investigational Site
Donauwoerth, Bayern, Germany, 86609
GSK Investigational Site
Ebersberg, Bayern, Germany, 85560
GSK Investigational Site
Eggenfelden, Bayern, Germany, 84307
GSK Investigational Site
Erlangen, Bayern, Germany, 91054
GSK Investigational Site
Forchheim, Bayern, Germany, 91301
GSK Investigational Site
Freising, Bayern, Germany, 85354
GSK Investigational Site
Fuerth, Bayern, Germany, 90766
GSK Investigational Site
Garmisch-Partenkirchen, Bayern, Germany, 82467
GSK Investigational Site
Kempten, Bayern, Germany, 87439
GSK Investigational Site
Kronach, Bayern, Germany, 96317
GSK Investigational Site
Landshut, Bayern, Germany, 84028
GSK Investigational Site
Landshut, Bayern, Germany, 84034
GSK Investigational Site
Marktredwitz, Bayern, Germany, 95615
GSK Investigational Site
Memmingen, Bayern, Germany, 87700
GSK Investigational Site
Muenchen, Bayern, Germany, 80331
GSK Investigational Site
Muenchen, Bayern, Germany, 80637
GSK Investigational Site
Muenchen, Bayern, Germany, 81925
GSK Investigational Site
Muenchen, Bayern, Germany, 80337
GSK Investigational Site
Muenchen, Bayern, Germany, 80335
GSK Investigational Site
Muenchen, Bayern, Germany, 81675
GSK Investigational Site
Muhr, Bayern, Germany, 91735
GSK Investigational Site
München, Bayern, Germany, 80638
GSK Investigational Site
Nuernberg, Bayern, Germany, 90491
GSK Investigational Site
Nuernberg, Bayern, Germany, 90449
GSK Investigational Site
Regensburg, Bayern, Germany, 93053
GSK Investigational Site
Rosenheim, Bayern, Germany, 83022
GSK Investigational Site
Roth, Bayern, Germany, 91154
GSK Investigational Site
Schwandorf, Bayern, Germany, 92421
GSK Investigational Site
Traunstein, Bayern, Germany, 83278
GSK Investigational Site
Waldmuenchen, Bayern, Germany, 93449
GSK Investigational Site
Weiden, Bayern, Germany, 92637
GSK Investigational Site
Fuerstenwalde, Brandenburg, Germany, 15517
GSK Investigational Site
Koenigs Wusterhausen, Brandenburg, Germany, 15711
GSK Investigational Site
Luckenwalde, Brandenburg, Germany, 14943
GSK Investigational Site
Ludwigsfelde, Brandenburg, Germany, 14974
GSK Investigational Site
Bremerhaven, Bremen, Germany, 27574
GSK Investigational Site
Bad Soden, Hessen, Germany, 65812
GSK Investigational Site
Frankfurt, Hessen, Germany, 60596
GSK Investigational Site
Frankfurt, Hessen, Germany, 65929
GSK Investigational Site
Frankfurt, Hessen, Germany, 60389
GSK Investigational Site
Frankfurt am Main, Hessen, Germany, 60590
GSK Investigational Site
Fulda, Hessen, Germany, 36043
GSK Investigational Site
Hanau, Hessen, Germany, 63450
GSK Investigational Site
Kassel, Hessen, Germany, 34117
GSK Investigational Site
Kassel, Hessen, Germany, 34125
GSK Investigational Site
Limburg, Hessen, Germany, 65549
GSK Investigational Site
Marburg, Hessen, Germany, 35043
GSK Investigational Site
Offenbach, Hessen, Germany, 63069
GSK Investigational Site
Wiesbaden, Hessen, Germany, 65197
GSK Investigational Site
Wiesbaden, Hessen, Germany, 65191
GSK Investigational Site
Wiesbaden, Hessen, Germany, 65189
GSK Investigational Site
Wiesbaden, Hessen, Germany, 65199
GSK Investigational Site
Greifswald, Mecklenburg-Vorpommern, Germany, 17487
GSK Investigational Site
Guestrow, Mecklenburg-Vorpommern, Germany, 18273
GSK Investigational Site
Rostock, Mecklenburg-Vorpommern, Germany, 18059
GSK Investigational Site
Schwerin, Mecklenburg-Vorpommern, Germany, 19055
GSK Investigational Site
Stralsund, Mecklenburg-Vorpommern, Germany, 18435
GSK Investigational Site
Aurich, Niedersachsen, Germany, 26603
GSK Investigational Site
Braunschweig, Niedersachsen, Germany, 38100
GSK Investigational Site
Celle, Niedersachsen, Germany, 29223
GSK Investigational Site
Cuxhaven, Niedersachsen, Germany, 27474
GSK Investigational Site
Georgsmarienhuette, Niedersachsen, Germany, 49124
GSK Investigational Site
Goettingen, Niedersachsen, Germany, 37075
GSK Investigational Site
Goslar, Niedersachsen, Germany, 38642
GSK Investigational Site
Hameln, Niedersachsen, Germany, 31785
GSK Investigational Site
Hannover, Niedersachsen, Germany, 30559
GSK Investigational Site
Hannover, Niedersachsen, Germany, 30177
GSK Investigational Site
Hannover, Niedersachsen, Germany, 30625
GSK Investigational Site
Leer, Niedersachsen, Germany, 26789
GSK Investigational Site
Oldenburg, Niedersachsen, Germany, 26133
GSK Investigational Site
Oldenburg, Niedersachsen, Germany, 26121
GSK Investigational Site
Osnabrueck, Niedersachsen, Germany, 49074
GSK Investigational Site
Rotenburg (Wuemme), Niedersachsen, Germany, 27356
GSK Investigational Site
Stade, Niedersachsen, Germany, 21680
GSK Investigational Site
Stadthagen, Niedersachsen, Germany, 31655
GSK Investigational Site
Vechta, Niedersachsen, Germany, 49377
GSK Investigational Site
Westerstede, Niedersachsen, Germany, 26655
GSK Investigational Site
Bergisch Gladbach, Nordrhein-Westfalen, Germany, 51465
GSK Investigational Site
Bielefeld, Nordrhein-Westfalen, Germany, 33604
GSK Investigational Site
Bochum, Nordrhein-Westfalen, Germany, 44787
GSK Investigational Site
Bochum, Nordrhein-Westfalen, Germany, 44791
GSK Investigational Site
Bonn, Nordrhein-Westfalen, Germany, 53127
GSK Investigational Site
Bonn, Nordrhein-Westfalen, Germany, 53113
GSK Investigational Site
Bonn, Nordrhein-Westfalen, Germany, 53129
GSK Investigational Site
Duesseldorf, Nordrhein-Westfalen, Germany, 40225
GSK Investigational Site
Duesseldorf, Nordrhein-Westfalen, Germany, 40235
GSK Investigational Site
Duisburg, Nordrhein-Westfalen, Germany, 47166
GSK Investigational Site
Eschweiler, Nordrhein-Westfalen, Germany, 52249
GSK Investigational Site
Essen, Nordrhein-Westfalen, Germany, 45130
GSK Investigational Site
Essen, Nordrhein-Westfalen, Germany, 45131
GSK Investigational Site
Essen, Nordrhein-Westfalen, Germany, 45136
GSK Investigational Site
Essen, Nordrhein-Westfalen, Germany, 45122
GSK Investigational Site
Gummersbach, Nordrhein-Westfalen, Germany, 51643
GSK Investigational Site
Hamm-Heessen, Nordrhein-Westfalen, Germany, 59073
GSK Investigational Site
Herne, Nordrhein-Westfalen, Germany, 44623
GSK Investigational Site
Koeln, Nordrhein-Westfalen, Germany, 50935
GSK Investigational Site
Koeln, Nordrhein-Westfalen, Germany, 50677
GSK Investigational Site
Koeln, Nordrhein-Westfalen, Germany, 50937
GSK Investigational Site
Krefeld, Nordrhein-Westfalen, Germany, 47805
GSK Investigational Site
Leverkusen, Nordrhein-Westfalen, Germany, 51375
GSK Investigational Site
Minden, Nordrhein-Westfalen, Germany, 32429
GSK Investigational Site
Moenchengladbach, Nordrhein-Westfalen, Germany, 41061
GSK Investigational Site
Muelheim, Nordrhein-Westfalen, Germany, 45473
GSK Investigational Site
Muenster, Nordrhein-Westfalen, Germany, 48149
GSK Investigational Site
Muenster, Nordrhein-Westfalen, Germany, 48153
GSK Investigational Site
Olpe, Nordrhein-Westfalen, Germany, 57462
GSK Investigational Site
Porta Westfalica, Nordrhein-Westfalen, Germany, 32457
GSK Investigational Site
Solingen, Nordrhein-Westfalen, Germany, 42697
GSK Investigational Site
Troisdorf, Nordrhein-Westfalen, Germany, 53840
GSK Investigational Site
Velbert, Nordrhein-Westfalen, Germany, 42551
GSK Investigational Site
Wesel, Nordrhein-Westfalen, Germany, 46485
GSK Investigational Site
Witten, Nordrhein-Westfalen, Germany, 58452
GSK Investigational Site
Wuerselen, Nordrhein-Westfalen, Germany, 52146
GSK Investigational Site
Wuppertal, Nordrhein-Westfalen, Germany, 42105
GSK Investigational Site
Wuppertal, Nordrhein-Westfalen, Germany, 42109
GSK Investigational Site
Wuppertal, Nordrhein-Westfalen, Germany, 42283
GSK Investigational Site
Ludwigshafen, Rheinland-Pfalz, Germany, 67063
GSK Investigational Site
Mainz, Rheinland-Pfalz, Germany, 55131
GSK Investigational Site
Trier, Rheinland-Pfalz, Germany, 54290
GSK Investigational Site
Homburg, Saarland, Germany, 66421
GSK Investigational Site
Landstuhl, Saarland, Germany, 66849
GSK Investigational Site
Neunkirchen, Saarland, Germany, 66539
GSK Investigational Site
Saarbruecken, Saarland, Germany, 66113
GSK Investigational Site
Aschersleben, Sachsen-Anhalt, Germany, 06449
GSK Investigational Site
Halle, Sachsen-Anhalt, Germany, 06110
GSK Investigational Site
Halle, Sachsen-Anhalt, Germany, 06120
GSK Investigational Site
Magdeburg, Sachsen-Anhalt, Germany, 39130
GSK Investigational Site
Magdeburg, Sachsen-Anhalt, Germany, 39108
GSK Investigational Site
Stendal, Sachsen-Anhalt, Germany, 39576
GSK Investigational Site
Weissenfels, Sachsen-Anhalt, Germany, 06667
GSK Investigational Site
Chemnitz, Sachsen, Germany, 09116
GSK Investigational Site
Dresden, Sachsen, Germany, 01127
GSK Investigational Site
Dresden, Sachsen, Germany, 01307
GSK Investigational Site
Hoyerswerda, Sachsen, Germany, 02977
GSK Investigational Site
Leipzig, Sachsen, Germany, 04129
GSK Investigational Site
Leipzig, Sachsen, Germany, 04277
GSK Investigational Site
Radebeul, Sachsen, Germany, 01445
GSK Investigational Site
Rodewisch, Sachsen, Germany, 08228
GSK Investigational Site
Schkeuditz, Sachsen, Germany, 04435
GSK Investigational Site
Torgau, Sachsen, Germany, 04860
GSK Investigational Site
Zittau, Sachsen, Germany, 02763
GSK Investigational Site
Zwickau, Sachsen, Germany, 08060
GSK Investigational Site
Bad Oldesloe, Schleswig-Holstein, Germany, 23843
GSK Investigational Site
Flensburg, Schleswig-Holstein, Germany, 24939
GSK Investigational Site
Geesthacht, Schleswig-Holstein, Germany, 21502
GSK Investigational Site
Heide, Schleswig-Holstein, Germany, 25746
GSK Investigational Site
Henstedt-Ulzburg, Schleswig-Holstein, Germany, 24558
GSK Investigational Site
Itzehoe, Schleswig-Holstein, Germany, 25524
GSK Investigational Site
Kiel, Schleswig-Holstein, Germany, 24103
GSK Investigational Site
Kiel, Schleswig-Holstein, Germany, 24105
GSK Investigational Site
Luebeck, Schleswig-Holstein, Germany, 23538
GSK Investigational Site
Neumuenster, Schleswig-Holstein, Germany, 24534
GSK Investigational Site
Rendsburg, Schleswig-Holstein, Germany, 24768
GSK Investigational Site
Erfurt, Thueringen, Germany, 99085
GSK Investigational Site
Gera, Thueringen, Germany, 07548
GSK Investigational Site
Jena, Thueringen, Germany, 07743
GSK Investigational Site
Meiningen, Thueringen, Germany, 98617
GSK Investigational Site
Muehlhausen, Thueringen, Germany, 99974
GSK Investigational Site
Berlin, Germany, 10367
GSK Investigational Site
Berlin, Germany, 10713
GSK Investigational Site
Berlin, Germany, 14197
GSK Investigational Site
Berlin, Germany, 13589
GSK Investigational Site
Berlin, Germany, 10365
GSK Investigational Site
Berlin, Germany, 14169
GSK Investigational Site
Berlin, Germany, 10967
GSK Investigational Site
Berlin, Germany, 10117
GSK Investigational Site
Berlin, Germany, 10317
GSK Investigational Site
Berlin, Germany, 13125
GSK Investigational Site
Berlin, Germany, 12559
GSK Investigational Site
Brandenburg, Germany, 14770
GSK Investigational Site
Bremen, Germany, 28239
GSK Investigational Site
Bremen, Germany, 28209
GSK Investigational Site
Friedrichshafen, Germany, 88048
GSK Investigational Site
Hamburg, Germany, 20259
GSK Investigational Site
Hamburg, Germany, 22457
GSK Investigational Site
Hamburg, Germany, 20357
GSK Investigational Site
Hamburg, Germany, 22359
GSK Investigational Site
Hamburg, Germany, 22081
GSK Investigational Site
Hamburg, Germany, 20246
GSK Investigational Site
Wuerzburg, Germany, 97080
Greece
GSK Investigational Site
Athens, Greece, 15123
GSK Investigational Site
Athens, Greece, 115 22
GSK Investigational Site
Athens, Greece, 151 23
GSK Investigational Site
Athens, Greece, 115 27
GSK Investigational Site
Heraklion, Crete, Greece, 71110
GSK Investigational Site
Neo Faliro, Greece, 18547
GSK Investigational Site
Patra, Greece, 26504
GSK Investigational Site
Thessaloniki, Greece, 546 45
Hong Kong
GSK Investigational Site
Kowloon, Hong Kong
GSK Investigational Site
Tuen Mun, Hong Kong
Hungary
GSK Investigational Site
Budapest, Hungary, 1032
GSK Investigational Site
Budapest, Hungary, 1122
GSK Investigational Site
Budapest, Hungary, 1145
GSK Investigational Site
Budapest, Hungary, 1082
GSK Investigational Site
Győr, Hungary, 9023
GSK Investigational Site
Szeged, Hungary, 6720
GSK Investigational Site
Szombathely, Hungary, 9700
India
GSK Investigational Site
Gurgaon, India, 122002
GSK Investigational Site
Hyderabad, India, 500082
GSK Investigational Site
Kolkatta (W.B.), India, 700016
GSK Investigational Site
Mangalore, India, 575001
GSK Investigational Site
Mumbai, India, 400012
GSK Investigational Site
Nagpur, India, 440010
GSK Investigational Site
New Delhi, India, 110029
GSK Investigational Site
New Delhi, India, 110076
GSK Investigational Site
Trivandrum, India, 695011
Ireland
GSK Investigational Site
Dublin, Ireland, 9
GSK Investigational Site
Dublin, Ireland, 8
GSK Investigational Site
Dublin, Ireland, 7
GSK Investigational Site
Galway, Ireland
GSK Investigational Site
Limerick, Ireland
GSK Investigational Site
Sligo, Ireland
GSK Investigational Site
Tallaght, Dublin, Ireland, 24
GSK Investigational Site
Wilton, Cork, Ireland
Israel
GSK Investigational Site
Beer-Sheva, Israel, 84101
GSK Investigational Site
Haifa, Israel, 31096
GSK Investigational Site
Holon, Israel, 58100
GSK Investigational Site
Jerusalem, Israel, 91031
GSK Investigational Site
Kfar Saba, Israel, 44281
GSK Investigational Site
Netanya, Israel
GSK Investigational Site
Ramat Gan, Israel, 52621
GSK Investigational Site
Rehovot, Israel, 76100
GSK Investigational Site
Tel Aviv, Israel, 64239
Italy
GSK Investigational Site
Potenza, Basilicata, Italy, 85100
GSK Investigational Site
Avellino, Campania, Italy, 83100
GSK Investigational Site
Carpi (MO), Emilia-Romagna, Italy, 41012
GSK Investigational Site
Lugo (Ravenna), Emilia-Romagna, Italy, 48022
GSK Investigational Site
Meldola (FC), Emilia-Romagna, Italy, 47014
GSK Investigational Site
Ravenna, Emilia-Romagna, Italy, 48121
GSK Investigational Site
Rimini, Emilia-Romagna, Italy, 47900
GSK Investigational Site
Aviano (PN), Friuli-Venezia-Giulia, Italy, 33081
GSK Investigational Site
Udine, Friuli-Venezia-Giulia, Italy, 33100
GSK Investigational Site
Roma, Lazio, Italy, 00144
GSK Investigational Site
Roma, Lazio, Italy, 00135
GSK Investigational Site
Roma, Lazio, Italy, 00168
GSK Investigational Site
Viterbo, Lazio, Italy, 01100
GSK Investigational Site
Genova, Liguria, Italy, 16132
GSK Investigational Site
Alzano Lombardo (BG), Lombardia, Italy, 24022
GSK Investigational Site
Bergamo, Lombardia, Italy, 24127
GSK Investigational Site
Brescia, Lombardia, Italy, 25124
GSK Investigational Site
Brescia, Lombardia, Italy, 25123
GSK Investigational Site
Cremona, Lombardia, Italy, 26100
GSK Investigational Site
Lecco, Lombardia, Italy, 23900
GSK Investigational Site
Mantova, Lombardia, Italy, 46100
GSK Investigational Site
Milano, Lombardia, Italy, 20142
GSK Investigational Site
Milano, Lombardia, Italy, 20141
GSK Investigational Site
Milano, Lombardia, Italy, 20162
GSK Investigational Site
Monza, Lombardia, Italy, 20052
GSK Investigational Site
Pavia, Lombardia, Italy, 27100
GSK Investigational Site
Rozzano (MI), Lombardia, Italy, 20089
GSK Investigational Site
San Fermo della Battaglia (Co), Lombardia, Italy, 22020
GSK Investigational Site
Saronno (VA), Lombardia, Italy, 21047
GSK Investigational Site
Treviglio (BG), Lombardia, Italy, 24047
GSK Investigational Site
Varese, Lombardia, Italy, 21100
GSK Investigational Site
Fano (Pesaro Urbino), Marche, Italy, 61032
GSK Investigational Site
Fermo (AP), Marche, Italy, 63023
GSK Investigational Site
Asti, Piemonte, Italy, 14100
GSK Investigational Site
Biella, Piemonte, Italy, 13900
GSK Investigational Site
Candiolo (TO), Piemonte, Italy, 10060
GSK Investigational Site
Brindisi, Puglia, Italy, 72100
GSK Investigational Site
Lecce, Puglia, Italy, 73100
GSK Investigational Site
Monserrato (CA), Sardegna, Italy, 09042
GSK Investigational Site
Sassari, Sardegna, Italy, 07100
GSK Investigational Site
Palermo, Sicilia, Italy, 90146
GSK Investigational Site
Palermo, Sicilia, Italy, 90127
GSK Investigational Site
Ragusa, Sicilia, Italy, 97100
GSK Investigational Site
Firenze, Toscana, Italy, 50139
GSK Investigational Site
Firenze, Toscana, Italy, 50134
GSK Investigational Site
Lido di Camaiore (LU), Toscana, Italy, 55043
GSK Investigational Site
Livorno, Toscana, Italy, 57124
GSK Investigational Site
Montepulciano (Siena, Toscana, Italy, 53045
GSK Investigational Site
Pisa, Toscana, Italy, 56126
GSK Investigational Site
Poggibonsi (Siena), Toscana, Italy, 53036
GSK Investigational Site
Prato, Toscana, Italy, 59100
GSK Investigational Site
Trento, Trentino-Alto Adige, Italy, 38122
GSK Investigational Site
Chieti, Italy, 66100
GSK Investigational Site
Cosenza, Italy, 87100
Japan
GSK Investigational Site
Aichi, Japan, 464-8681
GSK Investigational Site
Chiba, Japan, 277-8577
GSK Investigational Site
Ehime, Japan, 791-0280
GSK Investigational Site
Fukuoka, Japan, 811-1395
GSK Investigational Site
Ibaraki, Japan, 305-8576
GSK Investigational Site
Kanagawa, Japan, 259-1143
GSK Investigational Site
Kyoto, Japan, 606-8507
GSK Investigational Site
Osaka, Japan, 530-8480
GSK Investigational Site
Osaka, Japan, 540-0006
GSK Investigational Site
Saitama, Japan, 350-1298
GSK Investigational Site
Tokyo, Japan, 101-8643
GSK Investigational Site
Tokyo, Japan, 113-8677
GSK Investigational Site
Tokyo, Japan, 104-8560
GSK Investigational Site
Tokyo, Japan, 104-0045
GSK Investigational Site
Tokyo, Japan, 135-8550
Korea, Republic of
GSK Investigational Site
Gyeonggi-do, Korea, Republic of, 410-769
GSK Investigational Site
Incheon, Korea, Republic of, 400-711
GSK Investigational Site
Seoul, Korea, Republic of, 110-774
GSK Investigational Site
Seoul, Korea, Republic of, 138-736
GSK Investigational Site
Seoul, Korea, Republic of, 135-710
GSK Investigational Site
Seoul, Korea, Republic of, 120-752
GSK Investigational Site
Suwon, Kyonggi-do, Korea, Republic of, 443-721
Malaysia
GSK Investigational Site
Kubang Kerian, Malaysia, 16150
GSK Investigational Site
Sarawak, Malaysia, 93586
Mexico
GSK Investigational Site
Toluca, Estado de México, Mexico, 50080
GSK Investigational Site
Merida, Yucatán, Mexico, 97500
GSK Investigational Site
Chihuahua, Mexico, 31000
GSK Investigational Site
Mexico City, Mexico, CP 14080
GSK Investigational Site
Mexico DF, Mexico, 01120
GSK Investigational Site
México D.F., Mexico, 11000
Netherlands
GSK Investigational Site
Amersfoort, Netherlands, 3818 ES
GSK Investigational Site
Amsterdam, Netherlands, 1081 HV
GSK Investigational Site
Amsterdam, Netherlands, 1066 CX
GSK Investigational Site
Arnhem, Netherlands, 6815 AD
GSK Investigational Site
Blaricum, Netherlands, 1261 AN
GSK Investigational Site
Delft, Netherlands, 2625 AD
GSK Investigational Site
Den Haag, Netherlands, 2545CH
GSK Investigational Site
Den Haag, Netherlands, 2512 VA
GSK Investigational Site
Eindhoven, Netherlands, 5623 EJ
GSK Investigational Site
Gouda, Netherlands, 2803 HH
GSK Investigational Site
Hoofddorp, Netherlands, 2130 AT
GSK Investigational Site
Hoogeveen, Netherlands, 7909 AA
GSK Investigational Site
Leeuwarden, Netherlands, 8934 AD
GSK Investigational Site
Leiden, Netherlands, 2333 ZA
GSK Investigational Site
Leidschendam, Netherlands, 2262 BA
GSK Investigational Site
Purmerend, Netherlands, 1441 RN
GSK Investigational Site
Rotterdam, Netherlands, 3083 AN
GSK Investigational Site
Rotterdam, Netherlands, 3075 EA
GSK Investigational Site
Sittard-geleen, Netherlands, 6162 BG
GSK Investigational Site
Tilburg, Netherlands, 5022 GC
GSK Investigational Site
Utrecht, Netherlands, 3582 KE
New Zealand
GSK Investigational Site
Hamilton, New Zealand, 2001
GSK Investigational Site
Newtown, Wellington, New Zealand, 6002
GSK Investigational Site
Palmerston North, New Zealand, 4414
Norway
GSK Investigational Site
Førde, Norway, 6807
GSK Investigational Site
Oslo, Norway, 0407
GSK Investigational Site
Oslo, Norway, 0310
GSK Investigational Site
Tromsø, Norway, 9038
Pakistan
GSK Investigational Site
Islamabad, Pakistan, 1590
GSK Investigational Site
Karachi, Pakistan, 74800
GSK Investigational Site
Karachi, Pakistan
GSK Investigational Site
Lahore, Pakistan, 53400
GSK Investigational Site
Lahore, Pakistan, 54600
Peru
GSK Investigational Site
Callao, Peru, Callao 2
GSK Investigational Site
Lima, Peru, Lima 11
GSK Investigational Site
Lima, Peru, Lima 13
GSK Investigational Site
Lima, Peru, Lima 34
Philippines
GSK Investigational Site
Cebu, Philippines, 6000
GSK Investigational Site
Quezon City, Philippines, 1102
GSK Investigational Site
Sampaloc Manila, Philippines, 1008
GSK Investigational Site
San Juan, Philippines, 1502
Poland
GSK Investigational Site
Bydgoszcz, Poland, 85-796
GSK Investigational Site
Elblag, Poland, 82-300
GSK Investigational Site
Gdansk, Poland, 80-211
GSK Investigational Site
Gdansk, Poland, 80-219
GSK Investigational Site
Gliwice, Poland, 44-101
GSK Investigational Site
Krakow, Poland, 31-115
GSK Investigational Site
Kraków, Poland, 31-108
GSK Investigational Site
Olsztyn, Poland, 10-228
GSK Investigational Site
Olsztyn, Poland, 10-226
GSK Investigational Site
Opole, Poland, 45-060
GSK Investigational Site
Rzeszow, Poland, 35-055
GSK Investigational Site
Szczecin, Poland, 71-730
GSK Investigational Site
Warszawa, Poland, 02-781
GSK Investigational Site
Wroclaw, Poland, 53-413
Romania
GSK Investigational Site
Bucharest, Romania, 022328
GSK Investigational Site
Bucharest, Romania, 050098
GSK Investigational Site
Bucuresti, Romania, 022328
GSK Investigational Site
Cluj-Napoca, Romania, 400015
GSK Investigational Site
Iasi, Romania, 700106
Russian Federation
GSK Investigational Site
Arkhangelsk, Russian Federation, 163045
GSK Investigational Site
Chelyabinsk, Russian Federation, 454087
GSK Investigational Site
Irkutsk, Russian Federation, 664035
GSK Investigational Site
Kazan, Russian Federation, 420029
GSK Investigational Site
Kirov, Russian Federation, 610021
GSK Investigational Site
Moscow, Russian Federation, 121359
GSK Investigational Site
Moscow, Russian Federation, 129 128
GSK Investigational Site
Moscow, Russian Federation, 115478
GSK Investigational Site
Moscow, Russian Federation, 115 478
GSK Investigational Site
Novosibirsk, Russian Federation, 630047
GSK Investigational Site
Omsk, Russian Federation, 644013
GSK Investigational Site
Orenburg, Russian Federation, 460021
GSK Investigational Site
Ryazan, Russian Federation, 390011
GSK Investigational Site
Samara, Russian Federation, 443066
GSK Investigational Site
St. Petersburg, Russian Federation, 197758
GSK Investigational Site
St. Petersburg, Russian Federation, 197022
GSK Investigational Site
Voronezh, Russian Federation, 394062
Singapore
GSK Investigational Site
Singapore, Singapore, 119082
Slovakia
GSK Investigational Site
Bratislava, Slovakia, 833 10
GSK Investigational Site
Bratislava, Slovakia, 812 50
GSK Investigational Site
Kosice, Slovakia, 041 91
GSK Investigational Site
Poprad, Slovakia, 058 01
GSK Investigational Site
Rimavska Sobota, Slovakia, 979 01
GSK Investigational Site
Zilina, Slovakia, 010 01
Slovenia
GSK Investigational Site
Ljubljana, Slovenia, 1000
South Africa
GSK Investigational Site
Capital Park, South Africa, 0002
GSK Investigational Site
Groenkloof, Pretoria, 0001, South Africa, 0081
GSK Investigational Site
Observatory, South Africa, 7925
GSK Investigational Site
Panorama, South Africa, 7500
GSK Investigational Site
Parktown, South Africa, 2193
GSK Investigational Site
Pretoria, South Africa, 0041
GSK Investigational Site
Pretoria, South Africa, 0081
GSK Investigational Site
Sandton, South Africa, 2199
GSK Investigational Site
Saxonwold, Johannesburg, South Africa, 2196
Spain
GSK Investigational Site
Alcoy/Alicante, Spain, 03804
GSK Investigational Site
Barakaldo (Vizcaya), Spain, 48903
GSK Investigational Site
Barcelona, Spain, 08035
GSK Investigational Site
Burgos, Spain, 09006
GSK Investigational Site
Cadiz, Spain, 11009
GSK Investigational Site
Castellón, Spain, 12002
GSK Investigational Site
Cordoba, Spain, 14004
GSK Investigational Site
Coria, Spain, 10800
GSK Investigational Site
Elda, Spain, 03600
GSK Investigational Site
Granada, Spain, 18014
GSK Investigational Site
Hospitalet de Llobregat (Barcelona), Spain, 08907
GSK Investigational Site
Huesca, Spain, 22300
GSK Investigational Site
La Laguna (Santa Cruz de Tenerife), Spain, 38320
GSK Investigational Site
Lerida, Spain, 25198
GSK Investigational Site
Lugo, Spain, 27003
GSK Investigational Site
Madrid, Spain, 28006
GSK Investigational Site
Madrid, Spain, 28033
GSK Investigational Site
Madrid, Spain, 28041
GSK Investigational Site
Madrid, Spain, 28034
GSK Investigational Site
Madrid, Spain, 28046
GSK Investigational Site
Madrid, Spain, 28007
GSK Investigational Site
Malaga, Spain, 29010
GSK Investigational Site
Mataro, Spain, 08034
GSK Investigational Site
Murcia, Spain, 30120
GSK Investigational Site
Murcia, Spain, 30008
GSK Investigational Site
Móstoles, Spain, 28935
GSK Investigational Site
Palma de Mallorca, Spain, 07010
GSK Investigational Site
Palma de Mallorca, Spain, 07198
GSK Investigational Site
Pamplona, Spain, 31008
GSK Investigational Site
Salamanca, Spain, 37007
GSK Investigational Site
San Sebastián, Spain, 20014
GSK Investigational Site
Santander, Spain, 39008
GSK Investigational Site
Santiago, Spain, 15705
GSK Investigational Site
Segovia, Spain, 40002
GSK Investigational Site
Sevilla, Spain, 41014
GSK Investigational Site
Sevilla, Spain, 41009
GSK Investigational Site
Tarrasa, Barcelona, Spain, 08221
GSK Investigational Site
Toledo, Spain, 45004
GSK Investigational Site
Valencia, Spain, 46014
GSK Investigational Site
Valencia, Spain, 46017
GSK Investigational Site
Zamora, Spain
GSK Investigational Site
Zaragoza, Spain, 50009
Switzerland
GSK Investigational Site
Aarau, Switzerland, 5001
GSK Investigational Site
Basel, Switzerland, 4031
GSK Investigational Site
Bellinzona, Switzerland, 6500
GSK Investigational Site
Bern, Switzerland, 3010
GSK Investigational Site
Chur, Switzerland, 7000
GSK Investigational Site
Lausanne, Switzerland, 1005
GSK Investigational Site
Locarno, Switzerland, 6600
GSK Investigational Site
St Gallen, Switzerland, 9007
GSK Investigational Site
Thun, Switzerland, 3600
GSK Investigational Site
Zuerich, Switzerland, 8091
GSK Investigational Site
Zürich, Switzerland, 8008
Taiwan
GSK Investigational Site
Kaohsiung, Taiwan, 807
GSK Investigational Site
Taichung, Taiwan, 404
GSK Investigational Site
Tainan County, Taiwan, 736
GSK Investigational Site
Taipei, Taiwan, 100
GSK Investigational Site
Taipei, Taiwan, 104
GSK Investigational Site
Taipei, Taiwan, 105
GSK Investigational Site
Taipei, Taiwan, 114
GSK Investigational Site
Taipei, Taiwan, 112
Thailand
GSK Investigational Site
Bangkok, Thailand, 10330
GSK Investigational Site
Bangkok, Thailand, 10400
GSK Investigational Site
Bangkok, Thailand, 10700
GSK Investigational Site
Chiangmai, Thailand, 50200
GSK Investigational Site
Hatyai, Songkhla, Thailand, 90110
GSK Investigational Site
Khon Kaen, Thailand, 40002
GSK Investigational Site
Phitsanulok, Thailand, 65000
Ukraine
GSK Investigational Site
Chernivtsi, Ukraine, 58013
GSK Investigational Site
Donetsk, Ukraine, 83092
GSK Investigational Site
Ivano-Frankivsk, Ukraine, 76018
GSK Investigational Site
Kharkiv, Ukraine, 61024
GSK Investigational Site
Kyiv, Ukraine, 03115
GSK Investigational Site
Lviv, Ukraine, 79031
GSK Investigational Site
Simferopol, Ukraine, 95023
GSK Investigational Site
Uzhgorod, Ukraine, 88014
GSK Investigational Site
Uzhorod, Ukraine, 88000
United Kingdom
GSK Investigational Site
Chelmsford, Essex, United Kingdom, CM1 7ET
GSK Investigational Site
Epping, Essex, United Kingdom, CM16 6TN
GSK Investigational Site
Prittlewell Chase, Essex, United Kingdom, SS0 0RY
GSK Investigational Site
Bristol, Gloucestershire, United Kingdom, BS2 8ED
GSK Investigational Site
Canterbury, Kent, United Kingdom, CT1 3NG
GSK Investigational Site
Manchester, Lancashire, United Kingdom, M20 4BX
GSK Investigational Site
Preston, Lancashire, United Kingdom, PR2 9HT
GSK Investigational Site
Northwood, Middlesex, United Kingdom, HA6 2RN
GSK Investigational Site
Edinburgh, Midlothian, United Kingdom, EH4 2XU
GSK Investigational Site
Headington, Oxford, Oxfordshire, United Kingdom, OX3 7LJ
GSK Investigational Site
Ashford, United Kingdom, TN24 0LZ
GSK Investigational Site
Bebington, United Kingdom, CH63 4JY
GSK Investigational Site
Blackpool, United Kingdom, FY3 8NR
GSK Investigational Site
Bournemouth, United Kingdom, BH7 7DW
GSK Investigational Site
Brighton, United Kingdom, BN2 5BE
GSK Investigational Site
Cardiff, United Kingdom, CF14 2TL
GSK Investigational Site
Cheltenham, United Kingdom, GL53 7AN
GSK Investigational Site
Cottingham, United Kingdom, HU16 5JQ
GSK Investigational Site
Dorchester, United Kingdom, DT1 2JY
GSK Investigational Site
Exeter, United Kingdom, EX2 5DW
GSK Investigational Site
Grimsby, United Kingdom, DN33 2BA
GSK Investigational Site
Guildford, United Kingdom, GU2 7XX
GSK Investigational Site
Gwynedd, United Kingdom, LL57 2PW
GSK Investigational Site
Ipswich, United Kingdom, IP4 5PD
GSK Investigational Site
Lancaster, United Kingdom, LA1 4RP
GSK Investigational Site
Leeds, United Kingdom, LS9 7TF
GSK Investigational Site
Lindley, huddersfield, United Kingdom, HD3 3EA
GSK Investigational Site
Liverpool, United Kingdom, L7 8XP
GSK Investigational Site
London, United Kingdom, NW1 2PG
GSK Investigational Site
London, United Kingdom, SW3 6JJ
GSK Investigational Site
London, United Kingdom, W2 1NY
GSK Investigational Site
London, United Kingdom, SW17 0QT
GSK Investigational Site
London, United Kingdom, EC1A 7BE
GSK Investigational Site
London, United Kingdom, W6 8RF
GSK Investigational Site
London, United Kingdom, SE1 9RT
GSK Investigational Site
London, United Kingdom, NW3 2QG
GSK Investigational Site
Maidstone, United Kingdom, ME16 9QQ
GSK Investigational Site
Margate, United Kingdom, CT9 4AN
GSK Investigational Site
Newcastle upon Tyne, United Kingdom, NE7 7DN
GSK Investigational Site
Nottingham, United Kingdom, NG5 1PB
GSK Investigational Site
Plymouth, United Kingdom, PL6 8DH
GSK Investigational Site
Poole, Dorset, United Kingdom, BH15 2JB
GSK Investigational Site
Portsmouth, United Kingdom, PO6 3LY
GSK Investigational Site
Romford, United Kingdom, RM7 0AG
GSK Investigational Site
Sheffield, United Kingdom, S10 2SJ
GSK Investigational Site
Shrewsbury, United Kingdom, SY3 8XQ
GSK Investigational Site
Southport, United Kingdom, PR8 6PN
GSK Investigational Site
St Helens, United Kingdom, WA9 3DA
GSK Investigational Site
Stoke on Trent, United Kingdom, ST4 6QG
GSK Investigational Site
Sutton, United Kingdom, SM2 5PT
GSK Investigational Site
Swansea, United Kingdom, SA2 8QA
GSK Investigational Site
Worthing, United Kingdom, BN11 2DH
Sponsors and Collaborators
GlaxoSmithKline
North Central Cancer Treatment Group
Breast International Group
NCIC Clinical Trials Group
Investigators
Study Director: GSK Clinical Trials GlaxoSmithKline
  More Information

No publications provided by GlaxoSmithKline

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: GlaxoSmithKline
ClinicalTrials.gov Identifier: NCT00490139     History of Changes
Obsolete Identifiers: NCT00609024
Other Study ID Numbers: EGF106708
Study First Received: June 20, 2007
Last Updated: April 3, 2014
Health Authority: Germany: Federal Institute for Drugs and Medical Devices
United States: Food and Drug Administration

Keywords provided by GlaxoSmithKline:
HER2/neu gene amplified
Early stage breast cancer
Adjuvant
ErbB2-overexpressing

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases
Trastuzumab
Lapatinib
Antineoplastic Agents
Therapeutic Uses
Pharmacologic Actions
Protein Kinase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action

ClinicalTrials.gov processed this record on April 15, 2014